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The theme of my Ph.D. research is the integration of microscale fluid mechanics 
with two fields: biology and optics to solve problems at the interface between life and 
physical sciences.  In detail, my graduate work revolves around the use microfluidics 
and focuses on creating “Rapid drug delivery devices for insect biorobots, and 
Optofluidic reconfigurable photonic systems”.  The first major thrust of my research 
has been in the development of a method to directly and reversibly control insect 
(Manduca sexta moth) flight using implanted microfluidics.  The idea is to fuse a 
living system with a rapid drug delivery component which releases chemical 
stimulants on command to exert control over the level of neuromuscular activity.  
More recently, I established a novel hybrid control approach for the insect biorobot 
manipulation that simultaneously employs both electrical and chemical stimulation 
signals to generate integrated biorobotic systems that can perform an array of flight 
maneuver operations.  Along with working on the insect cyborg projects, my 
graduate work has expanded into the field of optofluidics.  I have developed a 
reconfigurable photonic system which allows me to take advantage of the chemical 
and physical adaptability of liquid state photonics with the robustness and speed 
available from traditional solid state photonics.  Basically, by combining liquid and 
planar solid state components on a chip, I was able to establish a novel optical 
switching platform which is not only tunable and adaptive, but also fast, stable and 
user-friendly.
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CHAPTER 1 
INTRODUCTION 
1.1 Research Scope 
In this research I developed new ways that how microfluidics can be integrated 
with biology and optics.  Through the use of electrokinetically and electrochemically 
induced flows in small microchannels, I have been able to demonstrate an implantable, 
low power and rate controllable drug delivery systems for living insects and 
autonomous microsystems.  I have also demonstrated the implementation of liquid-
core / liquid-cladding waveguides into a conventional solid-state optics intended use 
for reconfigurable photonics.  
The first contribution from this research is the ability to create an electrokinetic 
rapid drug delivery system with an energy consumption of as little as 20 mJ.  
Compared to the diffusion based system, the rapid drug delivery system developed 
here shows with an improvement on the order of approximately 130-fold.  My second 
contribution is the demonstration of a method of exerting chemical control over insect 
flight activity and longevity, exploiting the use of immature stage implanted 
microfluidics to reversibly control the rate of metabolic output.  This was the first step 
towards to create an artificial insect nervous system where the controlled release of 
inhibitory or excitatory neurotransmitters could be accomplished in response to 
external stimuli.  Third, I developed the electrochemically induced rapid drug delivery 
system for in vitro vasopressin release.  Electrolysis based ejection builds up the 
pressure in the reservoir which then forces the contents out of the well, independent of 
the external environmental conditions.  My fourth contribution is the demonstration of 
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the integrated microsystem that uses both chemical and electrical methods to modulate 
the flight activity of Manduca sexta moths for the first time.  35-fold improvement (on 
average 3 hours continuous flight) in flight longevity compared to mechanical 
stimulation has presented and 50% mean flight power output reduction can be 
achieved with the proper neurotransmitter dose.  Lastly, new approach to 
reconfigurable photonics which couples the physical adaptability of microfluidic 
waveguides to fiber-in and fiber-out optical systems has been demonstrated.  Two 
components that could form the basis of a more complex reconfigurable photonic 
system: a signal attenuator and a 1x2 optical switch have been shown.  
In the remainder of this chapter, I present a brief introduction to microfluidics and 
how it can be adopted into other fields.  I will motivate and explain why this field is 
important and what kind of useful toolbox can be made to answer complex problems 
especially in the interface between biology and physics.  I then present my 
accomplishments in Chapters 2 through Chapter 6 and conclude my findings for my 
work in Chapter 7. 
 
1.2 Microfluidics: Motivation 
Microfluidics is as it says a field of studying and investigating small scale fluid 
mechanics whose channel size is smaller than millimeter.  Researchers have already 
investigated how the fluids flow in small channel [1], mix [2] and the fluids and wall 
interfacial phenomena [3].  With regards to its applications, to date DNA, protein and 
cellular scale using microfluidic platform, mostly biological studies, have been paid a 
lot of attentions since fundamental spatial dimensions allow tremendous advantages 
[4].  For example, small dimension, thus small sensing volume (reduced to the same 
scale order as that of target [5]) requires extremely little quantities of samples and 
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analytes to perform biochemical reactions with high detection sensitivity [6].  Ideally, 
microfluidic platforms fundamentally can provide low cost with short time analyzing 
systems which are extremely attractive for many of the biological sensing applications 
[7].  
As briefly mentioned above, in the aspect of the biological application one of the 
main streams of the use of microfluidic devices is to interrogate biological events [8] 
or reconstitute the biological functions in a centimeter scale lab-on-a-chip devices [9, 
10].  For DNA analysis using microfluidic platforms, polymerase chain reaction 
(PCR), separation [11, 12], hybridization [13, 14], monitor [15] and detection [16, 17] 
methods have been extensively explored.  Protein analysis through microfluidics also 
have been studied including digestion [18, 19], identification and synthesis [20].  
Lastly, in cellular scale, microfluidics also have been integrated to cell handling [21], 
cytometry [22], manipulation [21] and sorting [23-25].  While such technology is 
extremely successful and useful, rarely has the extension been made to exerting active 
control over a living system.  The idea is that through microfluidic devices I tried to 
exert control over the biological system as a whole, yielding a microfluidically 
enabled biological system (Chap. 2-5).  In addition, this idea can be applied to other 
fields as well and I investigated microfluidics for optical systems that will be 
discussed below in Chap. 6. 
1.3 Microfluidic Applications Enabled Through My Work 
1.3.1: Chemical and electrical control over flying bio-robotic systems 
Microairvehicles are small unmanned aircrafts with a maximal wingspan of 
approximately 15 cm and flight speed below 10 m/s [26].  Such systems are of interest 
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[27] due to their capabilities to remote surveillance [28] and power harvesting [29, 
30].  Progress in micro-electro-mechanical-systems (MEMS) [31, 32] technology has 
enabled further miniaturization and improved control schemes in MAVs.  Wood et al. 
[33] reported small flying robots, flapping Diptera insects, however the downscaling 
of traditional air vehicles [34] is still a great challenges.  Particularly, through 
downsizing of the wing size compromises complex vehicle aerodynamics and most 
importantly the lack of a compact and lightweight high-density power source with a 
sufficiently long lifetime [34, 35] becomes the most challenging issue. 
Recently, in the name of “bio-inspired” engineering, researchers have been trying 
to overcome the power supplying concerns [36], for instance mimicking the body 
shapes, wing morphology and flapping motions that are present in nature [37-42].  
Bio-inspired MAVs have shown great possibility to solve the power supplying 
problems through emulating the complexity of nature however it is true that still they 
cannot outperform natural flyers in the near future.  On the other hand, living flyers, 
for example insects, have evolved perfectly in terms of flight dynamics and power 
efficiency.  In the aspect of the power supplying, many insects feed themselves 
tremendously a lot during pre-adult stage in the form of caterpillar (pre-adult stage) to 
store sufficient energy for their adult stage (i.e. Manduca sexta moths can live 
approximately two weeks with no food).  There is no doubt that these insect are of the 
best fliers however it is also reported that they are extremely difficult to be trained to 
perform useful flight [43].   
Rather than depending on pure MAVs or natural flyers, there have been efforts to 
form insect-MAVS as a revolutionary notion to create MAVs that exceed the flying 
performance.  Basically, the idea is that harnessing the living insects’ great flying 
capabilities and exerting flight control over flying insects through MEMS technologies.  
Bozkurt et al. [44] have reported aerodynamic operations including liftoff, yaw control 
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and landing and similar operations using Cotinis texana beetles were demonstrated by 
Sato et al. [45, 46] but all these works to are based on electrical stimulations. 
In this section of my work, I demonstrated a more localized method of exerting 
control over insect flight using chemical (implanted microfluidics) while taking 
advantage of electrical (implanted electrodes) control as well.  Microfluidic control 
can be the ideal method to modulate moths’ flight behavior since it can offers 
localized chemical release precisely that could mimic the actual chemical signal 
processes occurring inside of the body.  I demonstrated a drug delivery system (Chap. 
2 and 4 for device aspect and Chap. 3 and 5 for actual moth controls via microfluidics) 
affecting the insect nervous system and the flight activity and longevity of Manduca 
sexta moths. 
1.3.2: Optofluidics for reconfigurable photonics 
Field Programmable Gate Array (FPGA) [47] is a representative example of the on-
the-fly reconfigurable system in electronics via reprogramming the hierarchy of 
interconnections among logic blocks.  Users can easily re-program and engineer its 
output performance rapidly with low cost.  Interestingly, it is extremely hard to find 
the equivalent system or technology that has demonstrated near the level of 
reconfigurability of the FPGAs in other fields.  Especially in optics, in order to 
provide analogous tunability commonly two methods have been applied (1) varying 
the physical layout or (2) changing the refractive indices.  The recent advancements in 
MEMS also has benefited optics to dynamically vary the physical layout [48-50] 
though still relatively limited tunability has been provided.  With regards to the latter, 
various technologies have been reported including electro-optic [51, 52], magneto-
optic [53], acousto-optic [54, 55], thermo-optic [56], and carrier injection [57].  All of 
 6 
 
these techniques however are limited by the achievable ∆n/n, occasionally requiring 
either a longer interaction optical path length which is not desirable for miniaturized 
systems.  
Recent developments in optofluidics [58, 59]
 
have demonstrated much higher ∆n/n 
and been regarded as an alternative approach for higher reconfigurability.  For 
example, a number of pure liquid state photonic elements have been demonstrated 
such as waveguides [60, 61], microlenses [62, 63], and dye lasers [64, 65].  Liquid 
based photonic components have shown great tunability throughout flow rate 
adjustments, however little work has been reported that they can directly be 
incorporated into conventional solid-state photonic systems to be more practical.  In 
particular, the liquid-core and liquid-cladding waveguide system was reported by 
Wolfe et al. [60] but because of its innately high loss nature (diffusion between core 
and cladding fluids), liquid waveguide system has not been regarded as a practical 
optical element. 
I addressed mentioned problems by integrating the liquid-core / liquid-cladding 
waveguide into a fiber-in and fiber-out system.  In short, the liquid waveguide 
interconnects the optical fibers and through dynamic modulation of its shape via 
microfluidic flow controls I was able to develop a practical new type of photonic 
element for use in reconfigurable photonic and optical communication systems. 
1.4 Key Concepts and Background Theory 
1.4.2: Electrokinetic flow 
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Most of the flows in microfluidic channel are dominated by viscous effect (Re << 
1), thus, flows are considered under Stokes regime.  With this assumption, the Navier-
Stokes equation (in steady-state) can be simplified to Stokes equation as shown below.  
    ∇p−η∇
2
v = 0     (1.1) 
where, p is pressure, η is dynamic viscosity and v is flow velocity.  Also we assume 
the fluid medium is incompressible (Eq. 1.2).  The electric field is applied across 
microfluidic channel in order to induce the flow so that an electrostatic ρEE term has 
been added as a body force to Eq.1.1 yielding Eq. 1.3. 
      (1.2) 
∇p−η∇
2
v = ρE E     (1.3) 
where ρE is the volumetric charge density and E is external electrical field. 
Conventionally electrokinetic flow is mainly due to the combination of electroosmosis 
and electrophoresis (species) effects in response to the external electric ﬁeld and I will 
mainly discuss electroosmosis and electrophoresis that are specifically used in my 
drug delivery device described in Chap. 2. 
0∇⋅ =v
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Figure 1.1.  Schematic view of electrical double layer (EDL) and electroosmotic flow. 
1.4.2a: Electroosmosis 
As illustrated in Fig. 1.1, electroosmosis is referred to a plug type flow motion of 
the liquid in the microfluidic channel with an external electric field (Eext).  Normally 
the surface of the microfluidic channel is charged (here negatively) and due to 
Coulomb force the opposite charge ions form a thin cloud layer that we call the 
electrical double layer (EDL) [66].  In the bulk solution, the net charge is neutral but 
the near the wall (in the EDL) small net charge exists.  The potential difference 
between the wall and the bulk solution is defined as zeta potential (ζ).  With a uniform 
external electrical field and assumption of steady and isobaric flow Eq. 1.3 can be 
reduced to  
η∇
2
v + ρEEext=0      (1.4) 
By coupling Eq. 1.4 with the uniform permittivity (ε) and Poisson equation (shown 
below) in one dimensional configuration (see Fig. 1.1) we obtain, 
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      (1.5) 
and we can derive the bulk fluid flow velocity profile, vEO with assuming very thin 
EDL as follows. 
          vEO = -εζ/ηEext      (1.6) 
The term εζ/η is called as the electroosmotic mobility, µeo. 
 
Figure 1.2.  Schematic view of electrophoresis (regenerated from Dr. Bernardo Cor-
dovez’s original work).  No flow drag is shown. 
1.4.2b: Electrophoresis 
Chemical species can be migrated through fluid systems due to the presence of 
electrical fields.  Charged ions are transported in response to the Coulomb force and 
qualitatively this process is called electrophoresis.  The electrophoretic force is shown 
below. 
         FE=zeEext      (1.6) 
where e is the electron charge and z is the valence of the ion.   
2
Eε φ ρ− ∇ =
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1.4.3: Electrolysis 
Electrolysis of water is the breakdown of the H2O into oxygen (O2) and hydrogen 
gas (H2) through an oxidation and reduction reactions induced by DC potentials [67].  
Equations 1.7-9 show the detailed chemical reactions.   
Anode (oxidation): 2H2O (l) → O2 (g) + 4H
+ 
(aq) + 4e
–                  
(1.7) 
Cathode (reduction): 2H2O (g) + 2e
–
 → H2 (g) + 2OH
– 
(aq)              (1.8) 
Overall reaction: 2H2O (l) → 2 H2 (g) + O2 (g)               (1.9) 
Electrolysis has been introduced in this study as a pumping mechanism through 
building up a pressure in a confined reservoir to expel the liquid contents out through 
the dissolved membrane (see Chap. 4 for more details).  Occasionally, in vivo 
electrolysis is not desired for biomedical applications because that could possibly 
change the local pH changes, however in this study most of the electrolysis based 
ejection experiments were operated to avoid the pH changes.  In addition, the 
generated gases escape through internal insects’ gas expelling system [68]. 
1.4.4: Light propagation in waveguides 
It is almost impossible to obtain analytical solutions of how light propagates in the 
liquid-core / liquid-cladding waveguide however through overviewing the 
conventional solid-state waveguide case qualitative light transmission physics can be 
understood.  Starting from Maxwell’s equations, 
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     (1.8) 
     (1.9) 
     (1.10) 
     (1.11) 
where B is the magnetic flux density, D is the electric flux density, H is the 
magnetic field, J is the current density and we can derive wave equation as follows, 
     (1.12) 
and this can be solved using the method of separation of variables,  
                 (1.13) 
where E, ko, ni and β are the electric field, the free-space wavenumber, the refractive 
index of the medium and the propagation constant respectively.  For simplified 1D 
case, we can obtain a sinusoidal solution in the core (which determines mode 
profile) and an exponential decay solution in the claddings.  Numerically once the 
refractive index profile is obtained, light propagation within the waveguide can be 
solved [69].  With the help of my colleague Erica Jung, we reported a numerical 
study [69] on a hybrid system for coupling light between liquid- and solid-state 
waveguides, and I expanded this technique experimentally to develop two liquid 
t
∂
∇× = −
∂
B
E
t
∂
∇× = +
∂
P
H J
0∇⋅ =B
Eρ∇⋅ =D
2
2
0 2
0
t
µ ε
∂
∇ − =
∂
E
E
2 2 2
( ) 0o ik n β∇ + − =E E
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waveguide based photonic elements for use in reconfigurable photonic systems 
which are discussed in detail in Chap. 6. 
1.5 Research Overview and Dissertation Breakdown 
Chapter 2 is the demonstration of a rapid, low power and implantable drug delivery 
system, intended for use with autonomous microsystems.  To date most of the current 
drug delivery devices or systems rely on the diffusion based chemical delivery but the 
drug release mechanism developed in my graduate work utilizes the electrokinetic 
effects (discussed in Section 1.4.1-2) to control both the release time and rate of 
chemicals.  The fundamental advantage of the system is that this can rapid deliver the 
drugs from hours to second over previous diffusion based approaches with energy 
consumption of as little as 20 mJ.  Furthermore, the device can be applied to the 
situation where rapid dosage or pulsatile manner release are needed for biomedical 
applications that are discussed in Chap. 4.   
Chapter 3 presents the direct application of the electrokinetic drug delivery device 
for autonomous systems.  I developed, for the first time, a method that directly and 
reversibly engineers insect flight metabolics using implanted microfluidics.  Detailed 
injection and implantation experiments are also presented in this chapter.  This chapter 
also explores how injected chemicals can modulate the internal level of moths’ 
metabolic rates by monitoring respiratory CO2 output.  Throughout chemical injection, 
behaviors ranging from retarded motion to complete, reversible paralysis, are 
presented.  This work shows the possibility of a new paradigm for insect flight control 
alongside established electrical techniques. 
Chapter 4 presents a next generation version of the electrolysis based drug delivery 
systems for biomedical use presented in Chapter 2.  In this chapter, I developed and 
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discussed an implantable microreservoir based devices that enable delivery of 15 µl of 
vasopressin using an electrochemically based transport mechanism.  Administration of 
vasopressin release plays a crucial role in compensatory mechanism for restoring 
blood pressure during hemorrhagic shock [70, 71].  Characterizations of vasopressin 
delivery via electrochemical transport mechanism are explored and the device was 
directly implemented into insect-MAVs that are presented in Chap 5.  
Chapter 5 discusses an integrated microsystem that uses both chemical and 
electrical methods to modulate the flight activity and longevity of Manduca sexta 
moths.  The electrical component of the system initiates and maintains tetherless flight 
by applying electrical pulses to an antenna lobe and an implanted microfluidic 
component modulates flight speed and output power by administering a 
neurotransmitter dose to the central nervous system.  In short, the implanted 
microfluidic device was used to eject a neurotransmitter solution into a Manduca sexta 
moth’s thorax resulting in a reversible and chemically induced mid-flight flight 
control.  Furthermore, in this chapter I presented that the electrical stimulation 
provides as much as 35-fold enhancement in flight duration with respect to mechanical 
approach and that a 50% mean flight power output reduction can be achieved with the 
proper neurotransmitter dose. 
In Chap. 6, I shifted the topics from microfluidically enabled biology to optics.  
The developments of two liquid-core / liquid-cladding waveguide based photonic 
elements: an optical switch or signal attenuator, are presented for use in reconfigurable 
photonic systems.  In this work, I was able to demonstrate the ability to couple light 
between conventional optical fibers through interconnecting them with the liquid 
waveguide.  Small scale flow control enabled the reconfigurable shape and position of 
the liquid waveguide yielding an attenuation range of 3.1-10.7 dB and a 1x2 sub-
second switching system with a maximum coupling efficiency of 3.87 dB.  
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Chapter 7 concludes the work presented by summarizing my research contributions 
to microfluidics and their impacts with additional remarks. 
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CHAPTER 2 
ELECTROKINETIC MICROFLUIDIC DEVICES FOR RAPID, LOW POWER 
DRUG DELIVERY IN AUTONOMOUS MICROSYSTEMS
*
 
2.1 Abstract 
In this work, a low power and robust electroactive microwell-based implantable 
drug delivery system, intended for use with autonomous microsystems, is presented.  
The device comprises of an upper silicon based structure in which the drug storage 
sites are defined and a lower electrically functionalized PDMS (poly-
dimethylsiloxane) backing.  The drug ejection mechanism developed here exploits 
localized electrokinetic effects to control both the release time and release rate of 
chemicals stored in independent well sites.  It is shown how this can reduce the dosage 
time from hours to second over previous diffusion based approaches using as little as 
20 mJ of energy per dose.  This paper focuses on presenting the design and 
characterizing the electrokinetic transport mechanics which govern the release time 
and dispersal pattern of the well contents using a series of experimental and numerical 
techniques. 
 
 
 
 
 
 
 
 
 
                                                 
*
Reproduced by permission of the Royal Society of Chemistry with permission from Aram J. Chung, 
Donn Kim and David Erickson, "Electrokinetic microfluidic devices for rapid, low power drug delivery 
in autonomous microsystems", Lab-on-a-Chip, 8, 330-338 (2008) DOI: 10.1039/B713325A 
The original publication is available at: 
http://pubs.rsc.org/en/Content/ArticleLanding/2008/LC/b713325a 
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2.2 Introduction 
Autonomous microsystems can be defined as “systems, enabled through 
microfabrication technology, that function of their own accord with the ability to 
interpret and interact with their environment”.  Recent developments in micro-electro-
mechanical-systems or MEMS [1, 2] component-level technology (including power 
generation [3], energy storage, communications, sensing, and subcomponent 
assembly) have brought the development of such systems closer to a reality.  While 
many of the initial thrusts into this field were directed towards autonomous sensor 
networks [4], the integration of bioMEMS [5-8] and microfluidic elements [9-12] in 
these types of devices is increasingly finding application to in-vitro and in particular 
in-vivo medical devices (mostly through various “smart-pill” type technologies) [13, 
14].  While such systems are becoming increasingly functional, their primary use 
remains diagnostic rather than therapeutic.  One of the limitations of these devices, 
and all autonomous microsystems, is that the power load is relatively large compared 
with the amount of energy available from current battery technology.  This tends to 
significantly limit the lifetime of the device. 
Oral, nasal, intravenous, pulmonary and transdermal methods represent the 
traditional and often preferred routes for drug delivery.  Broadly speaking the 
advantage of the former of these is its relative simplicity, while the later methods have 
been developed to enable more rapid delivery and better specific organ targeting [15].  
The advantages that emerging MEMS based implantable drug delivery systems offer 
over these conventional methods are controllability (i.e. the ability to autonomously 
deliver very precise doses either periodically or in response to a sensor event), 
delivery speed and microscopic localization [16, 17].  Such capabilities could have 
significant impact on future human health [18].
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Current implantable drug delivery systems [19-21] can be categorized as either 
passive or active [16].  Passive systems are based on chemical release beginning 
immediately after implantation (either through a diffusive processes or mechanical 
pumping) and continuing until the “on-board” dose is depleted.  Though this offers 
control over the total dose, neither the delivery timing nor its rate can be manipulated 
by the physician, patient or the system itself.
16 
One of the first experimental demonstrations of an active drug delivery was 
described by Santini et al. [22]  In their system an array of individually sealed 
reservoirs were fabricated on a silicon microchip and filled with a series of different 
chemicals.  The system could then be implanted and the contents of each reservoir 
released by applying an external electric potential (which induced electrochemical 
dissolution of the gold sealing membrane).  This active control over the delivery 
timing and dosage can have a significant effect on its therapeutic efficacy in that the 
specific drug and its dosage can be released rapidly in consideration of the patients’ 
current condition.  Such systems have the advantage of a relatively simple 
construction, requiring only low voltage electrical actuation as opposed to mechanical 
pumping. 
Drug release from self-contained reservoirs relies on a diffusive transport 
mechanism.  This allows for continuous releases of contents over an extended period 
of time which could take several hours to days depending on the diffusion coefficient 
of the chemical [22-24].  Thus while the dose initiation time can be manipulated, the 
delivery rate remains fixed to this relatively slow rate.  In certain cases it is desirable 
to possess greater control over the release rate to allow for more rapid dosage (in order 
to better respond to the patient’s condition) or to better mimic a physiological release 
profile.  For example insulin and other hormones are well-known to be secreted by the 
body in a pulsatile manner.  Deficiency in hormones of the anterior pituitary gland 
 26 
 
such as thyroid stimulating hormone, growth hormone, luteinizing hormones regulated 
by the hypothalamus may lead hypothyroidism (insufficient production of thyroid 
hormone), hypoglycemia/dwarfism (inadequate production of growth hormone) or 
hypogonadism (failure of gonadal function).  Pulsatile administration of small 
volumes of thyroid releasing hormone, growth hormone releasing hormone [24] and 
gonadotropin releasing hormone [24] can help the severity of these deficiencies. 
In this work, we present an electroactive microwell [25] based drug/chemical 
delivery system which provides this active chip control over the delivery rate, timing 
and speed without the need for significant additional on-chip architecture or large 
power consumption.  A series of single and multiple well chips were fabricated, all of 
which used the two component construction.  As shown in Fig. 2.1, the silicon layer 
contained the drug well(s) and the upper set of electrodes, while the PDMS layer 
served to seal the well and hold the lower electrode.  The device structure is a 
modification of that presented by Santini et al. [22], exploiting the same 
electrochemical dissolution technique to expose the contents, but incorporating 
electrical functionality onto a flexible PDMS backing to enable control over the 
electrokinetic transport.  As will be described below, the technique is based on 
exploiting highly localized electrokinetic transport to rapidly exchange the contents of 
the well with the external environment.  This allows for a controlled reduction in the 
total dosage time to seconds rather than hours as will be demonstrated.  Here we focus 
on presenting the overall design and construction of the device, and detailing the 
delivery rate and drug dispersion pattern as a function of the strength of the applied 
electric field.  A detailed 3D finite element analysis of the transport dynamics of the 
system is conducted in order to better understand the governing mechanisms behind 
the ejection process.  As alluded to above, this device is designed for use in 
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autonomous microfluidic systems and thus a detailed analysis of the voltage, power 
and energy requirements is also conducted. 
 
Figure 2.1.  (a) Schematic representative section of an electroactive microwell drug 
delivery system developed here.  Inset: cross sectional view of the system (b) 
Fabricated and assembled device with electrical leads connected to thin copper wires.   
2.3 Materials and methods 
In this materials and methods section we begin with a detailed description of the 
device fabrication and assembly procedure (A detailed process diagram of the 
fabrication and assembly procedure is also included as supplementary material).  The 
final two subsections describe the device operation and experimental procedure. 
2.3.1 Microfabrication  
In our device we have used double side polished, (100) n-doped silicon wafers with 
a thickness of 500 µm.  In general thicker wafers were preferred in order to maximize 
the well volume.  To fabricate the devices we first used low pressure chemical vapour 
deposition (LPCVD) to deposit a 200 nm thick layer of silicon nitride on both sides of 
the wafer.  760 µm squares were then reactive ion etched into the back side silicon 
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nitride layer defining the eventual location of the wells.  Following this a 300 nm layer 
of gold was evaporated and patterned using image reversal contact lithography process 
on the top surface to form the electrode leads and well membrane.  A polyimide 
(Durimide
®
) passivation layer was then deposited on the topside of the wafer which 
served to electrically isolate the electrodes from the electrolyte solution during 
membrane dissolution.  The passivation layer was patterned using an aluminium mask 
and oxygen plasma etching process so that only the eventual location of the membrane 
and surrounding C-shape gold features would be exposed to the solution (See Fig. 
2.1c).  The microwells were then defined by immersing the wafer in KOH for roughly 
8 hours.  During this process the exposed silicon was etched along the crystal plane 
resulting in the square pyramidal shape shown in Fig. 2.1a.  Lastly, the remaining 
nitride on backside of the wafer and underneath the gold membrane were etched by 
reactive ion etching.  The resulting drug wells were 760 µm square at the base and 52 
µm square at the top resulting in a total cavity volume of approximately 100 nL. 
To create the lower gold patterned PDMS layer we used a similar technique to that 
described by Lee et al. [26] 100 nm thick gold features were first patterned on a 
silicon substrate.  After the gold features were created an MPTMS (3-mercaptopropyl-
trimethoxysilane) film was deposited onto the top surface of the wafer using molecular 
vapour deposition (MVD).  The MPTMS layer served as an organic adhesion layer 
aiding with the transfer of the gold features from the silicon wafer to the PDMS [27].  
After surface modification, a 5:1 (base:linker) mixture of PDMS was spin coated at 
100 rpm for 30 seconds onto the wafer to a final thickness of approximately 580 µm.  
The PDMS was then cured at 80°C for 90 minutes and the final structures were cut out 
of the mold (Fig. 2.2d). 
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2.3.2 Microchip Assembly 
The microwell reservoir was filled with a phosphate buffered saline (PBS) using 
36G blunt syringe (NanoFil
TM
, World Precision Instrument).  A PBS buffer solution 
concentrated such that it had similar chloride ion concentration to that found in human 
sera [28] was used here.  For the flow visualization experiments, 1.9 µm fluorescent 
polystyrene microspheres (Duke Scientific) were added to the PBS solution.  Once 
filled the upper (silicon) and the bottom (PDMS) substrates were placed in conformal 
contact with each other and bonded together. 
The use of a PDMS substrate greatly facilitated robust sealing of the device.  In 
general, as long as wells were not overfilled, the conformal contact the PDMS formed 
with the polished bottom of the silicon microchip was sufficient to ensure a watertight 
seal.  Significant overfilling of the wells tended to result in bursting of the gold 
membrane when the PDMS backing was applied.  This is a result of the liquid being 
largely incompressible and thus very little overfilling was required in order to increase 
the internal pressure above that of the membrane burst pressure.  To avoid this here we 
slightly under filled the wells (leaving a small compressible air pocket). 
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Figure 2.2.  (a) Stage 1: To electrochemically dissolve the membrane a potential is 
applied between the two upper electrodes.  (b) Stage 2:  After dissolution to eject the 
contents, the potentials applied between the upper electrode and the lower one on the 
PDMS.  (c) Magnified view of microchip from above looking at the region near the 
membrane.  Pale yellow regions (membrane and C-shape gold features) are gold 
where the polyimide layer was etched.  (d) An example of gold-PDMS bottom 
substrate  
2.3.3 Detailed device operation 
Device operation occurs in two stages.  As shown in Fig. 2.2a, in the first stage the 
potential is applied between two electrode pads on top of the microchip serving to 
electrochemically dissolve the membrane [29], exposing the contents to the external 
environment (this was similarly demonstrated by Santini et al.
 
[22]).  To 
electrokinetically eject the contents from the well, in the second stage a potential field 
is applied between one of the upper electrodes and that on the PDMS at the bottom of 
the well, as illustrated in Fig. 2.2b.  The application of this DC voltage (between 3-4 
volts) over the relatively small wafer thickness results in extremely high electric field 
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strength (just under 10
5
 V/m) localized in the well [25].  As will be characterized in 
detail below, the resulting electrokinetic transport dramatically reduced the amount of 
time required to eject the contents of the well over diffusive transport [22-24] (from 
hours to minutes) with very little energy consumption.  In all cases a Hewlett-Packard 
6234A dual output power supply was used to apply these potentials and a Keithley 
236 SMU (Source-Measure Unit) was used to record the current load.  The transport 
of the microspheres was recorded using Unibrain Fire-i
TM
 software and a Sony XCD-
X710 camera. 
2.3.4 Biocompatibility 
Although the focus of this paper is on device design and transport analysis it is 
important to briefly discuss the biocompatibility of the architecture introduced here.  
In a recent paper, Voskerician et al. [30] reported on the in vivo biocompatibility and 
biofouling of many of the fabrication materials used here (i.e. gold, silicon nitride, 
silicon) in the context of similar microsystem drug delivery devices.  In general it was 
found that of these materials silicon was the least biocompatible though it can undergo 
a number of simple surface passivation processes, such as silanation, to improve its 
performance.  For the remaining materials used here, Richardson et al. [31] and 
Belanger and Marois [32] have reported polyimide and PDMS respectively as 
exhibiting good biocompatibility. 
2.4 Results and discussions 
The electroactive microwell drug delivery system described here allows the well 
contents to be stored indefinitely until a dose command is given, after which it can be 
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rapidly released.  As mentioned above, the use of an electrochemical membrane 
dissolution technique to expose the contents of a microwell to the external 
environment was previously demonstrated by Santini et al. [22] In the following two 
subsections therefore we focus on characterizing the novel aspects of the device 
reported here, namely the electrokinetically enhanced ejection times and low power 
operation consumption. 
For completeness however we report that for our device a 5.0 V dc bias was 
applied between the upper electrodes as shown in Fig. 2.2a in order to initiate 
membrane dissolution.  At this potential the resulting electrochemical reaction 
required 6 to 7 seconds to release the membrane, exposing the well contents to the 
external environment.  Lower biases resulted in much longer membrane release times.  
Further details on the process are available in the “Power consumption” section below. 
 
Figure 2.3.  Time lapse illustrating the ejection of 1.9 µm fluorescent polystyrene 
microsphere particles from an electroactive microwell.  (a) After dissolution of the 
membrane, the fluorescent particles can be seen in the well.  White lines outline the 
gold electrodes features.  (b)-(f) frames taken every two seconds (total of 10 seconds) 
after application of a 4.0 V potential.  
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2.4.1 Electrokinetic enhanced ejection 
Immediately following dissolution of the membrane the applied potential field is 
switched to the configuration shown in Fig. 2.2b (i.e. between the upper and lower 
electrodes) and the resulting electrokinetic transport ejects the stored contents from the 
well to the external environment.  Time lapse images in Fig. 2.3 illustrate the effect for 
the case of an applied potential of 4.0 V using the fluorescent flow tracers described 
above (see movie in supplemental material).  As can be seen the process results in an 
approximately radial dispersal pattern.  To characterize the dispersal pattern as a 
function of applied potential, the maximum dispersal radius was recorded as a function 
of time for 3.0 V, 3.5 V, 3.75 V and 4.0 V respectively.  These measurements were 
performed using a similar sets of images to those shown in Fig. 2.3 which were 
processed using ImageJ (http://rsb.info.nih.gov/ij/) and a self-written MATLAB 
routine (Mathworks, Natick, MA).  This range of applied potentials was used as they 
represent an optimal between expected ejection time
 
[25] and power consumption 
(which will be characterized in the following section). 
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Figure 2.4.  (a) Dispersion radius vs. time for different applied potentials (b) 
Instantaneous front velocity as a function of time.  
The results of these experiments are presented in Figs. 2.4a and 2.4b, which show 
the dispersion radius and instantaneous transport front velocity as a function of time 
for different voltages.  In all these cases the front was tracked to a distance of 500 µm, 
limited by the field of view of our microscope.  As can be seen there exists an 
extremely strong dependence of the system dispersion on the applied electrokinetic 
potential with the 4.0 V case representing an average of a 15 fold improvement in both 
front velocity and dispersion radius over the 3.0 V case.  A detailed analysis of the 
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superposition and relative importance of the electroosmotically induced convection 
and electrophoretic transport during the ejection process is provided in the 
“Characterization of electrokinetic transport” section below. 
 
Figure 2.5.  Time required to completely empty the contents of the microwell as a 
function of applied potential.  
The time required to empty the microwell of its original contents is plotted in Fig. 
2.5 again as a function of applied potential.  The well was determined to be empty 
when fluorescent tracer particles could no longer be seen exiting the well.  As can be 
seen at 3.0 V roughly 10 minutes was required to completely exchange the contents 
which was reduced to just over 2 minutes at 4.0 V.  Earlier diffusion based approaches 
required several hours [22-24] to completely eject the contents and thus, for cases 
where rapid on-command chemical delivery is required, this represents an 
improvement on the order of approximately 130 fold. 
As is apparent from the above, in addition to reducing the overall ejection time, the 
electrokinetic technique also provides a method for controllably modulating the 
delivery rate through simple adjustment of the applied potential.  While some existing 
transdermal microneedle systems [33] also posses this capability, the simplicity of the 
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fabrication, assembly and operation (no fragile or moving parts nor complex or 
pulsatile pumping procedures) suggest that this approach may be more robust.  The 
approach presented fuses the advantages of microwell devices, in terms of simplicity 
and storage stability, with the delivery flexibility afforded by microneedle systems. 
 
Figure 2.6.  (a) Average power load during ejection process (b) Total energy 
consumed to completely empty the well using the times from Fig. 2.5.  The line 
through the data points in this figure represents a quadratic best fit.  
2.4.2 Power consumption 
As mentioned in the introduction, one of the most significant limitations to the 
development of autonomous microsystems is the relatively small amount of energy 
which can be stored and voltage which can be generated with existing battery 
technology.  As such minimizing voltage, power and energy requirements becomes a 
critical aspect of sub-component design.  The small distance over which the potential 
is applied allows us to generate high field strengths (and therefore rapid electrokinetic 
transport) without the need for large applied potentials.  To determine the power 
requirements and energy consumption of both the membrane dissolution and 
electrokinetic ejection stages used here a Keithley 236 Source-Measure Unit was used 
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to monitor the current load.  Over the course of the 7 seconds required to dissolve the 
membrane at an applied potential of 5.0 V, an average power load of 3.70 mW was 
recorded resulting in 26 mJ of energy consumed.  Fig. 2.6 plots the power load (6a) 
and energy consumption (6b) for the same ejection voltages used in Fig. 2.4.  The 
energy consumption was obtained by multiplying the average power load (Fig. 2.6a) 
by the time required to completely empty the well (Fig. 2.5).  As can be seen for 3.0 V 
an average power load of 44 µW was measured resulting in a total energy 
consumption of 26 mJ.  By comparison at 4.0 V the average power load was 497 µW 
resulting in 68 mJ of energy consumed.  As can be seen from Fig. 2.6b, which plots 
the total energy required to empty the well as a function of applied voltage, there 
exists a clear minimum of around 20 mJ in the region between 3.0 V and 3.5 V.  Note 
that this minimum is based on an interpolation of the quadratic curve fit used in Fig. 
2.6b.  The lowest actual measured power consumption was 22 mJ at 3.5 V.  Although 
not optimal for rapid delivery, this region would be the best operational zone for low 
energy consumption.  As can be seen from Fig. 2.6a the power load begins the 
increase quite dramatically after 3.5 V.  This is partially due to the fact that power 
should vary with the square of the applied voltage (for fixed resistance) however there 
is also likely additional effects which contribute like ohmic heating.  Ohmic heating 
would serve to decrease the well’s resistivity and therefore increase the current load on 
the system resulting in a larger than squared dependence on applied voltage.  The 
minimum energy load region observed here represents the regime before the power 
load begins to spike and after the time required to empty the well has begun to 
drastically decrease from that observed at lower applied potentials. 
For comparison representative existing drug delivery dosing actuation systems [34] 
are shown in Table 2.1.  As can be seen they typically require on the order of 100s of 
mW for operation or relatively high voltage.  The device presented here represents a 
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good combination of low voltage requirements and power draw.  Based on these 
results the electroactive microwell system developed here appears to be a good 
candidate for adding drug delivery functionality to next generation autonomous 
microsystems. 
Table 2.1.  Comparison of power consumption of dosing systems  
Working principle   V (V) Power (mW) 
Electrostatic micropump [35] 200 1 
Thermo-pneumatic
 
[36] 15 450 
Magnetohydrodynamic micropump
 
[37] 10 18 
Bubble-type planar micropump [38] 40 1000 
Ionic conductive polymer film micropump [39] 1.5 180 
Electroactive microwell 4 0.5 
2.4.3 Characterization of electrokinetic transport 
To characterize the various electrokinetic transport processes involved in the 
ejection stage, a three-dimensional finite element model (FEM) of the system was 
constructed.  The computational domain used here matched exactly that shown in Fig. 
2.1a, comprising of both the well and a large exterior domain selected to be large 
enough to mimic the external environment.  For reasons that will be expanded on later, 
the upper electrodes were also incorporated into the model. 
Details of the modelling procedures and general assumptions are available in earlier 
works [40] and thus here we focus on the specifics of this implementation.  For the 
purposes of this model, we assume that the solution electrical and thermophysical 
properties are the same inside and outside the well and thus the applied potential field, 
φ, can be modelled with a simple Laplacian 
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     (2.1) 
Matching the experimental conditions as closely as possible, cathodic potentials 
were applied along the upper electrode and a ground (0V) potential was set along the 
bottom of the well.  With the exception of the electrode domains, electrical insulation 
conditions were applied along all other boundaries (∂φ/∂n=0, where n is the surface 
normal).  Figure 2.7 illustrates the potential field lines obtained from these 
simulations.  All calculations shown here and below were implemented using the 
COMSOL finite element package. 
 
Figure 2.7.  Computed electric field lines in electroactive microwell  
The electroosmotic flow field, v, was computed by solving the low Reynolds 
number incompressible Stokes flow equations, 
     (2.2) 
     (2.3) 
2 0φ∇ =
2 0pη∇ −∇ =v
0∇⋅ =v
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(where η is the viscosity and p is the pressure) subject to electroosmotic slip, veo, 
conditions at four walls of microwell and the top surface of the device.  The slip 
velocity was calculated using the Helmholtz-Smoluchowski equation veo = -εζE/η, 
where ε is the permittivity of the medium, ζ is the surface zeta potential and E is the 
field strength (E = -∇φ) evaluated tangential to the boundary.  For the purposes of 
these simulations ζ = -60 mV was used, as has been reported for silicon dioxide 
surfaces under similar electrolyte conditions to those used in our experiments [40], due 
to the expected growth of a native oxide layer on the silicon after exposure to air.  The 
remaining surfaces were assigned free slip (∂v/∂τ=0, where τ is the tangential to the 
surface), zero penetration (v⋅n=0) boundary conditions. 
Transient species transport was modelled using the modified convection diffusion 
equation, 
     (2.4) 
where c is the local species concentration, t is the time and D is the diffusion 
coefficient.  The convective component from Eq. (3) comprises of both the bulk 
electroosmotic flow, v from Eq. (2a), and the electrophoretic velocity of the 
transported species evaluated using vep= µepE, where µep is the electrophoretic 
mobility.  For the polystyrene fluorescent microspheres used here the electrophoretic 
mobility was computed using µep = εζ/η with ζ = -40 mV [41].
 
2 ( )ep
c
D c c
t
∂
= ∇ − + ⋅∇
∂
v v
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Figure 2.8.  Finite element simulations of the transport process (a) Transport 
streamlines for pure electroosmosis (b) Streamlines when all electrokinetic effects are 
considered.  Colour contours show applied potential ranging from blue (ground) to red 
(maximum potential). 
Figure 2.8 shows a two dimensional cut view of the electrical potential distribution 
and transport streamlines (v + vep) during the ejection process.  To better understand 
the ejection process we consider two cases: Fig. 2.8a, pure electroosmotic flow, and 
Fig. 2.8b, both electroosmotic and electrophoretic components.  From Fig. 2.8a it can 
be seen that the applied potential induces a strong electroosmotic flow component 
very near the wall, dragging fluid from the external environment into the well.  This 
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then displaces the contents of the well which is ejected through the middle of the 
outlet.  The dragging of the fluid from the external environment back into the well is 
demonstrated experimentally in the second supplemental movie 
(chung_LOC_movie2.wmv).  In this movie the motion of the tracer particles back into 
the well is clearly illustrated suggesting the flow mechanism described above is at 
qualitatively accurate.  
 
Figure 2.9.  Finite element analysis of time-dependent species transport.  Images show 
cut view of species concentration every 5 seconds up to 25 seconds after the ejection 
process  (a) Electroosmosis only  (b) Electrophoresis and electroosmosis. 
This is also illustrated in Fig. 2.9a which plots the transient convection-diffusion 
solution, Eq. (3), in the well for a species with a diffusion coefficient equivalent to that 
of the polystyrene spheres used in the experiment and an applied potential of 3.5 V.  
When the electrophoretic component is included, Fig. 2.8b, the electroosmotic 
recirculation regions become confined to an area very near the wall.  This is reflected 
in Fig. 2.9b where the much more rapid ejection of the contents is apparent since the 
electrophoretic ejection process dominates.  Note that while the majority of the well 
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contents are emptied after 25 seconds, the electroosmotic flow tends to pull back into 
the well some of the ejected species resulting in the more concentrated regions along 
the wall, most evident in the final two timeframes.  This accounts for the experimental 
observation that while the initial dispersion occurs quite rapidly (Fig. 2.3) the amount 
of time to completely empty the well is much longer (Fig. 2.5).  Since these 
simulations suggest that the majority of the contents are ejected during the first 20 
seconds to 25 seconds the empty times shown in Fig. 2.5 represent an upper limit.  
 
Figure 2.10.  Plot comparing experimental and numerical results on the 3.5 V case. 
To further validate the numerical results we compare the dispersion radius 
measured experimentally with that obtained from the simulations shown in Fig. 2.9b.  
The results are shown in Fig. 2.10 for the 3.5 V case.  As can be seen the trends 
between the two cases are very similar with the numerical results tending to over-
predict the dispersion radius over the first 8 seconds of the process.  The reason for 
this is likely due to uncertainties in the electrophoretic mobility of the polystyrene 
beads in the buffer solution used here and an over estimate of the applied potential (we 
ignored any potential drops along the leads or at the solution/electrode interface).  In 
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general however neither of these would affect the overall transport mechanisms 
described above. 
2.5 Summary and conclusion 
We have demonstrated here an implantable, low power and rate controllable drug 
delivery device incorporating an electroactive microwell structure.  This approach 
serves to actively repel the drugs inside the well using a combination of electroosmotic 
and electrophoretic effects which are controlled through an electric potential applied 
between the top and bottom of the well.  The contents dispersal rate and energetic 
consumption of the device were characterized experimentally.  It was found that the 
ejection process could be completed in less than 2 minutes or using as little as 20 mJ 
of energy, both of which compared favourably to the state of the art.  Detailed 3D 
numerical simulations were used to model the electrokinetic transport involved in the 
ejection process.  In addition to providing a physical insight in to the transport 
mechanism, the simulations revealed that the majority of the contents are ejected early 
in the process. 
2.6 Acknowledgement 
This work was supported by the Defense Advanced Research Project Agency, 
Microsystems Technology Office, Hybrid Insect MEMS (HI-MEMS) program, 
through the Boyce Thompson Institute for Plant Research.  Distribution unlimited.  
Fundamental research exempts from prepublication controls.  We would also like to 
acknowledge helpful discussions from Bernardo Cordovez and Likun Chen. 
 
 45 
 
REFERENCES 
1. Tanaka, M., An industrial and applied review of new MEMS devices features. 
Microelectron. Eng., 2007. 84(5-8): p. 1341-1344. 
2. Gad-el-Hak, M., MEMS : design and fabrication. 2006, Boca Raton: CRC 
Press. 
3. Beeby, S.P., M.J. Tudor, and N.M. White, Energy harvesting vibration sources 
for microsystems applications. Measurement Science & Technology, 2006. 
17(12): p. R175-R195. 
4. Warneke, B., M. Last, B. Liebowitz, and K.S.J. Pister, Smart dust: 
Communicating with a cubic-millimeter computer. Computer, 2001. 34(1): p. 
44-+. 
5. Bashir, R., D. Akin, R. Gómez, H. Li, W.-J. Chang, and A. Gupta. From 
bioMEMS to bionanotechnology: Integrated biochips for the detection of cells 
and microorganisms. in Proceeding of material research society. 2003. 
6. Bhattacharya, S., J.S. Jang, L.J. Yang, D. Akin, and R. Bashir, Biomems and 
nanotechnology-based approaches for rapid detection of biological entities. 
Journal of Rapid Methods and Automation in Microbiology, 2007. 15(1): p. 1-
32. 
7. Bhushan, B., Nanotribology and nanomechanics of MEMS/NEMS and 
BioMEMS/BioNEMS materials and devices. Microelectronic Engineering, 
2007. 84(3): p. 387-412. 
8. Madou, M., J. Zoval, G.Y. Jia, H. Kido, J. Kim, and N. Kim, Lab on a CD. 
Annual Review of Biomedical Engineering, 2006. 8: p. 601-628. 
 46 
 
9. Dittrich, P.S. and A. Manz, Lab-on-a-chip: microfluidics in drug discovery. 
Nature Reviews Drug Discovery, 2006. 5(3): p. 210-218. 
10. Erickson, D. and D. Li, Integrated microfluidic devices. Analytica Chimica 
Acta, 2004. 507(1): p. 11-26. 
11. Abgrall, P. and A.M. Gue, Lab-on-chip technologies: making a microfluidic 
network and coupling it into a complete microsystem - a review. Journal of 
Micromechanics and Microengineering, 2007. 17(5): p. R15-R49. 
12. Yi, C.Q., C.W. Li, S.L. Ji, and M.S. Yang, Microfluidics technology for 
manipulation and analysis of biological cells. Analytica Chimica Acta, 2006. 
560(1-2): p. 1-23. 
13. Eliakim, A.R., Video capsule endoscopy of the small bowel (PillCam SB). 
Current Opinion in Gastroenterology, 2006. 22(2): p. 124-127. 
14. Dickman, R. and R. Fass, Ambulatory esophageal pH monitoring: New 
directions. Digestive Diseases, 2006. 24(3-4): p. 313-318. 
15. Orive, G., R.M. Hernandez, A.R. Gascon, A. Dominguez-Gil, and J.L. Pedraz, 
Drug delivery in biotechnology: present and future. Current Opinion in 
Biotechnology, 2003. 14(6): p. 659-664. 
16. Maloney, J.M., S.A. Uhland, B.F. Polito, N.F. Sheppard, C.M. Pelta, and J.T. 
Santini, Electrothermally activated microchips for implantable drug delivery 
and biosensing. Journal of Controlled Release, 2005. 109(1-3): p. 244-255. 
17. Ahmed, A., C. Bonner, and T.A. Desai, Bioadhesive microdevices with 
multiple reservoirs: a new platform for oral drug delivery. J. Control. Release, 
2002. 81(3): p. 291-306. 
18. Grayson, A.C.R., R.S. Shawgo, A.M. Johnson, N.T. Flynn, Y.W. Li, M.J. 
Cima, and R. Langer, A BioMEMS review: MEMS technology for 
 47 
 
physiologically integrated devices. Proceedings of the IEEE, 2004. 92(1): p. 6-
21. 
19. Kim, M.S., K.S. Seo, H. Hyun, S.K. Kim, G. Khang, and H.B. Lee, Sustained 
release of bovine serum albumin using implantable wafers prepared by 
MPEG-PLGA diblock copolymers. International Journal of Pharmaceutics, 
2005. 304(1-2): p. 165-177. 
20. Arky, R., ed. Physician's Desk Reference 1998, Medical Economics Company: 
Montvale, NJ, USA. 
21. Arky, R., ed. Physician's Desk Reference 1998, Medical Economics Company: 
Montvale, NJ, USA. 3139. 
22. Santini, J.T., M.J. Cima, and R. Langer, A controlled-release microchip. 
Nature, 1999. 397(6717): p. 335-338. 
23. Scheidt, R.A., J.T. Santini, Jr., A.C. Richards, A.M. Johnson, A. Rosenberg, 
M.J. Cima, and R. Langer. Microchips as implantable drug delivery devices. in 
Microtechnologies in Medicine and Biology, 1st Annual International, 
Conference On. 2000. 2000. 
24. Santini, J.T., A.C. Richards, R. Scheidt, M.J. Cima, and R. Langer, Microchips 
as controlled drug-delivery devices. Angewandte Chemie-International 
Edition, 2000. 39(14): p. 2397-2407. 
25. Cordovez, B., D. Psaltis, and D. Erickson, Trapping and storage of particles in 
electroactive microwells. Applied Physics Letters, 2007. 90(2). 
26. Lee, K.J., K.A. Tosser, and R.G. Nuzzo, Fabrication of stable metallic 
patterns embedded in poly(dimethylsiloxane) and model applications in non-
planar electronic and lab-on-a-chip device patterning. Advanced Functional 
Materials, 2005. 15(4): p. 557-566. 
 48 
 
27. Ling, T.G.I., M. Beck, R. Bunk, E. Forsen, J.O. Tegenfeldt, A.A. Zakharov, 
and L. Montelius, Fabrication and characterization of a molecular adhesive 
layer for micro- and nanofabricated electrochemical electrodes. 
Microelectronic Engineering, 2003. 67-8: p. 887-892. 
28. Fitzsimons, E. and J. Sendroy, Distribution of Electrolytes in Human Blood. J. 
Biol. Chem., 1961. 236(5): p. 1595-1601. 
29. Frankenthal, R.P. and D.J. Siconolfi, The Anodic Corrosion of Gold in 
Concentrated Chloride Solutions. J. Electrochem. Soc., 1982. 129(6): p. 1192-
1196. 
30. Voskerician, G., M.S. Shive, R.S. Shawgo, H.v. Recum, J.M. Anderson, M.J. 
Cima, and R. Langer, Biocompatibility and biofouling of MEMS drug delivery 
devices. Biomaterials, 2003. 24(11): p. 1959-1967. 
31. Richardson Jr, R.R., J.A. Miller, and W.M. Reichert, Polyimides as 
biomaterials: preliminary biocompatibility testing. Biomaterials, 1993. 14(8): 
p. 627-635. 
32. Belanger, M.C. and Y. Marois, Hemocompatibility, biocompatibility, 
inflammatory and in vivo studies of primary reference materials low-density 
polyethylene and polydimethylsiloxane: A review. Journal of Biomedical 
Materials Research, 2001. 58(5): p. 467-477. 
33. Henry, S., D.V. McAllister, M.G. Allen, and M.R. Prausnitz, Microfabricated 
microneedles: A novel approach to transdermal drug delivery. Journal of 
Pharmaceutical Sciences, 1998. 87(8): p. 922-925. 
34. Tsai, N.C. and C.Y. Sue, Review of MEMS-based drug delivery and dosing 
systems. Sensors and Actuators a-Physical, 2007. 134(2): p. 555-564. 
 49 
 
35. Zengerle, R., J. Ulrich, S. Kluge, M. Richter, and A. Richter, A bidirectional 
silicon micropump. Sensors and Actuators A: Physical, 1995. 50(1-2): p. 81-
86. 
36. Schomburg, W.K., J. Vollmer, B. Bustgens, J. Fahrenberg, H. Hein, and W. 
Menz, Microfluidic components in LIGA technique. Journal of 
Micromechanics and Microengineering, 1994. 4: p. 186-191. 
37. Jang, J.S. and S.S. Lee, Theoretical and experimental study of MHD 
(magnetohydrodynamic) micropump. Sensors and Actuators a-Physical, 2000. 
80(1): p. 84-89. 
38. Zahn, J.D., A. deshmukh, A.P. Pisano, and D. Liepmann, Continuous On-Chip 
Micropumping for Microneedle Enhanced Drug Delivery. Biomedical 
Microdevices, 2004. 6(3): p. 183-190. 
39. Guo, S., T. Nakamura, T. Fukuda, and K. Oguro. Development of the micro 
pump using ICPF actuator. in Proc. IEEE ICRA. 1997. 
40. Erickson, D. and D. Li, Microscale Flow and Transport Simulation for 
Electrokinetic and Lab-on-Chip Applications. Biomems and Biomedical 
Nanotechnology, Volume IV: Biomolecular Sensing, Processing and Analysis 
ed. R. Bashir and S. Wereley. 2006: Kluwer Academic Publishing. 
41. Kirby, B.J. and E.F. Hasselbrink, Zeta potential of microfluidic substrates: 2. 
Data for polymers. Electrophoresis, 2004. 25(2): p. 203-213. 
 
 
 50 
 
CHAPTER 3 
ENGINEERING INSECT FLIGHT METABOLICS USING IMMATURE 
STAGE IMPLANTED MICROFLUIDICS
*
 
3.1 Abstract 
Small-scale insect inspired aircraft represent a promising approach to downscaling 
traditional aircraft designs.  Despite advancements in microfabrication however it has 
proven difficult to fully replicate the mechanical complexities that enable these natural 
systems.  As an alternative, recent efforts have used implanted electrical, optical or 
acoustic microsystems to exert direct control over insect flight.  Here we demonstrate, 
for the first time, a method of directly and reversibly engineering insect flight 
metabolics using immature stage implanted microfluidics.  We present our technique 
and device for on-command modulation of the internal levels of L-Glutamic and L-
Aspartate acids and quantify the resulting changes in metabolic activity by monitoring 
respiratory CO2 output.  Microfluidic devices implanted 1 to 2 days prior to insects’ 
emergence achieved survivability and flight-capable rates of 96% and 36%, 
respectively.  Behavior ranging from retarded motion to complete, reversible paralysis, 
over timescales ranging from minutes to hours is demonstrated.  Such a system could 
form the basic component of an eventual artificial insect nervous system. 
 
 
 
 
 
                                                 
*
Reproduced by permission of the Royal Society of Chemistry with permission from Aram J. Chung 
and David Erickson, "Engineering insect flight metabolics using immature stage implanted 
microfluidics", Lab-on-a-Chip, 9, 669-676 (2009) DOI: 10.1039/B814911A 
The original publication is available at: 
 http://pubs.rsc.org/en/Content/ArticleLanding/2009/LC/b814911a 
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3.2 Introduction 
Micro-air-vehicles (MAVs) are small aircraft with a maximal wingspan of 
approximately 15 cm and flight speed below 10 m/s [1].  Such systems are of 
significant interest to the military, industrial and academic communities largely as a 
result of their potential to perform bio-chemical sensing in hazardous locations, long-
range surveillance and stealthy reconnaissance [2].  Rapid progress in micro-electro-
mechanical-systems (MEMS) [3, 4] technology (including power generation, energy 
storage, communications, sensing, and subcomponent assembly) has enabled further 
miniaturization and improved performance in these systems, however to date they still 
suffer from small payload capacity, large size or poor flight stability, and short 
operational time [5-7].  The latter of these is a particularly important limitation and 
results from the technical challenges involved in creating a compact and lightweight 
high-density power source with a sufficiently long lifetime [8, 9]. 
As a result of the challenges in downscaling traditional aircraft designs, a number 
of researchers have looked to the natural world to develop bio-inspired MAVs [10]; 
for instance mimicking the body shapes, wing shapes and flapping patterns that are 
present in nature [11-16].  Emulating the vast complexity of nature however has 
proven to be an extremely difficult engineering problem and thus man-made systems 
are unlikely to outperform natural flyers (particularly in terms of flight dynamics and 
power efficiency) in the near future.  Flying insects, for example, have evolved an 
aerodynamic shape that allows them to remain stable in turbulent air conditions and a 
complex wing flapping motion with an extremely energy efficient stroke [17].  Many 
insects spend the majority of their pre-adult lives constantly feeding in order to store 
sufficient energy (in the form of glucose) to sustain them throughout their adult lives.  
Additionally, large flying moths such as Manduca sexta or Ascalapha odorata are able 
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to carry payloads well in excess of one gram without significant degradation of their 
natural flight mechanics [18, 19]. 
The ability of flying insects to meet or exceed the performance capabilities of 
current MAVs has lead to recent interest in integrating MEMS technology with these 
living systems in order to exert some level of flight control over them.  Bozkurt et al. 
[20, 21] for example reported direct electrical control over the flight of a Manduca 
sexta (M. Sexta) moth by implanting microfabricated electrical probes at the pupal 
stage.  In that work the probes were used to send biphasic electrical pulses into the 
flight muscles enabling effective control over wing motion.  They demonstrated down- 
and up-stroke actuation of each wing separately, which affected the flight direction of 
moth.  Also using electrical stimulation, Sato et al. [22] demonstrated control over 
beetle flight using an implanted and tetherless microsystem and Ando and Kanzaki 
[23] presented longitudinal control in freely flying hawkmoths.  Recently, Ritzmann et 
al. [24] demonstrated the possibility of controlling the locomotor activity of a 
cockroach using brain nerve group stimulation.  With the aim of developing a 
technique for powering these devices, Reissman and Garcia [25] recently presented a 
power harvesting system aimed at extracting energy from the natural vibrations that 
occur during insect flight using surgically inserted piezoelectric materials and 
inductor-coils. 
Here we demonstrate a more intimate method of exerting control over insect flight, 
exploiting the use of immature stage implanted microfluidics to reversibly engineer 
the rate of flight metabolism.  In this paper we present our technique for modulating 
the internal levels of a series of different chemicals known to affect the insect nervous 
system (specifically L-Glutamic and L-Aspartate acids) and thereby demonstrate 
dynamic control over metabolic output using microfluidics.  In this study we use M. 
sexta moths as our model species due to its large potential payload capacity and 
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excellent flight capability.  The insect has a large body mass (~2 g), a wingspan of 10 
cm and a potential flight range of kilometers.  In addition to demonstrating the 
technique, we present here details of the implantation surgeries, injection experiments 
and microfluidic device.  Changes in the rate of metabolic activity are quantified using 
a novel flight stimulation apparatus and by monitoring changes in CO2 output.  We 
demonstrate the ability to provide rapid chemical paralysis (from full flight activity to 
no motion) which lasts for several hours.  Partial insect recovery is observed after 3 
hours with full recover in less than 22 hours.  We propose that that system is the first 
step towards the development of an artificial insect nervous system. 
 
Figure 3.1.  (a) A schematic view of the developmental stages of a M. sexta moth.  
Insertion of the microfluidic device is conducted at the pupal stage of development. (b 
and c) Device insertion surgeries are done in the dorsal thorax with the microfluidic 
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chip inserted approximately 5 mm into the pupa. Then wound is sealed with 
biocompatible glue. (d and e) M. sexta moth successfully emerged with an implanted 
device.   
3.3 Materials and methods 
In this materials and methods section we begin with a detailed description of the 
implantation, injection process, device fabrication, and assembly procedure.  The final 
subsection describes the respirometry system used to determine resting metabolic rate. 
3.3.1 Implantation process  
The microfluidic devices were implanted in M. sexta pupae, approximately 1 or 2 
days before the adult insects were scheduled to emerge.  Prior to the surgery, the 
pupae were placed on ice for approximately 25 minutes to minimize their movement 
and lower the inner body pressure.  Using a sterilized scalpel, the dorsal exoskeleton 
and body skin were cut away and the device was partially implanted into the thorax 
near the dorsolongitudinal flight muscles (dl muscle).  During implantation the device 
is gently inserted into thorax to minimize the disruption to the aorta which passes 
nearby.  To seal the wounds after surgery a viscous and fast curing biocompatible glue 
(Loctite® 454: ISO 10993, Henkel) was used.  The rapid curing of the glue prevented 
penetration into body. 
3.3.2 Injection process 
A number of different chemicals were tested to gauge their effectiveness in 
generating the desired physiological response in given the limitations outlined in the 
 55 
 
text.  To gauge their performance direct injection experiments were conducted by first 
folding the wings then inserting a needle (700 series syringes, Hamilton) containing 
the test drug into different locations along the insect (specifically the dorsal/ventral 
thorax, the head and every segment of the abdomen).  The following chemicals were 
tested in various different concentrations and dissolved with 10 mM phosphate 
buffered saline (pH 7.4): γ-aminobutyric acid (Sigma-Aldrich), Taurine (Sigma-
Aldrich), β-alanine (Sigma-Aldrich), Atropine (Sigma-Aldrich), Malathion (Sigma-
Aldrich), Scorpion venom (Hadrurus arizonensis, Spider Pharm), L-Aspartate acid 
potassium salt hemihydrates (Sigma-Aldrich), and L-Glutamic acid potassium salt 
monohydrate (Sigma-Aldrich).  The insect response was gauged visually. 
 
Figure 3.2.  (a) Schematic of the electroactive microwell drug delivery system 
developed here. (b) Fabricated and assembled electrokinetic microfluidic devices used 
here.  The devices measure 4 x 22 x 2.5 mm and weigh 250 mg.  (c) Microchip 
assembly: (1) an upper silicon based structure, (2) Parylene deposited PDMS reservoir, 
and (3) electrically functionalized Pyrex bottom substrate are bonded together by the 
plasma treatment.  
3.3.3 Microfabrication 
The microfluidic device presented here consists of three layers; silicon layer 
contained the microwell and the upper set of electrodes, Parylene deposited PDMS 
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macro reservoir, and a Pyrex bottom substrate which served to seal the reservoir and 
hold the lower electrode.  The top silicon layer was fabricated using the same methods 
as described previously by Chung et al. [26].  Briefly, silicon nitride was deposited on 
both sides of the (100) n-doped silicon wafer and the backside was etched to define the 
location of the wells.  Following this, gold electrodes were evaporated and patterned, 
and then Polyimide dielectric layer was spun and etched.  The microwells were then 
defined by immersing the wafer in KOH and remaining silicon nitride underneath gold 
membrane was removed by reactive ion etching.  To create the PDMS macro 
reservoir, a 10:1 (base: linker) mixture of PDMS was cured at 80°C for 60 minutes, 
and the final structure was cut out, and then placed on the microscope slide glass.  
Transparent 3M scotch® tape was attached on top of the PDMS structure which 
allows depositing Parylene only at the sidewalls of the reservoir.  The PDMS surface 
was modified by oxygen plasma prior to the Parylene deposition in order to improve 
the adhesion between Parylene and PDMS [27, 28].  Following this, 1 µm thick 
Parylene (Parylene C, Specialty Coating Systems) was deposited using Parylene 
deposition tool (PDS 2010 Labcoter, Specialty Coating Systems), and then the scotch 
tape was removed.  Lastly, to fabricate the bottom Pyrex layer, 10 nm/100 nm layers 
of titanium/gold were evaporated and patterned using image reversal contact 
lithography process to form the electrode pads and leads. 
3.3.4 Microchip assembly 
The upper (silicon), the middle (PDMS), and the bottom (Pyrex) substrates were 
placed in conformal contact with each other and bonded together by the plasma 
treatment and cured in the 80°C oven for overnight.  After the microchip assembly, a 
PEG (Poly-ethylene glycol) film was coated on the entire surface of the assembled 
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device using molecular vapor deposition tool (MVD 100, Applied MicroStructures) to 
minimize the physiological response since PEG deposition is a well known 
biocompatible surface molecular modification [29].  The microwell and macro 
reservoir were filled with different chemicals using micro-liter syringe (NanoFilTM, 
World Precision Instrument) through the slit, sealed with biocompatible wax (Butler 
GUM, Sunstar).  The final full loaded device weighs approximately 0.3 g which is the 
15% of the total insect’s body mass and the payload capacity. 
3.3.5 Respirometry to determine resting metabolic rate 
Metabolic rates were measured using a flow-through respirometry chamber.  The 
insect ventral thorax was glued onto a narrow beam and the stage was mounted inside 
of the chamber.  Dry, CO2 free air was went through the 3-liter respirometry chambers 
first for 5 minutes to set up the baseline for the resting metabolic rate, and then the 
insect was mechanically stimulated to initiate a flight response (which will be 
described more in the “Quantification of the metabolic rate” section below).  To 
measure the continuous changes in CO2 level reflective of the metabolic output of the 
insect, all the air from the jar passed through the carbon dioxide analyzer (Li-Cor 6252, 
Lincoln), and data were collected. 
3.4 Results and discussions 
3.4.1 Implantation 
As shown in Fig. 3.1, the microfluidic device is partially implanted within the M. 
sexta dorsal thorax at the pupal stage of development.  Consistent with the ideas 
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described in Bozkurt et al. [20, 21] and used in Paul et al. [30], implantation is done at 
an immature developmental stage.  The reason for this is that wounds which occur 
during the implantation surgery are known to heal better during the natural molting 
process [31, 32].  It is expected that this results in a smaller physiological footprint, 
since the device has been carried through a greater portion of the insect’s 
development.  Earlier works [22-24, 33] have relied on adult stage implantations.  Fig. 
3.1a outlines the M. sexta lifecycle, illustrating the stage in its development at which 
the implantations done here were conducted.  To determine the optimal implantation 
strategy that minimizes the physiological footprint and maximizes survivability, we 
performed a number of insertion experiments varying the timing of the implantation 
(see Fig. S3.1 in supplemental material) and location (see Fig. S3.2 in supplemental 
material).  We chose to conduct implantation at two different time periods, relatively 
early (approximately 1 week prior to emergence) and relatively late (1-2 days prior to 
emergence).  As shown in the supplemental material test implants were conducted at 
numerous different parts of the body.  The impact of the implants was gauged visually 
post emergence by noting which insects exhibited malformed extremities (wings) or 
poor flight characteristics.  We define a system with “poor flight capability” as one 
which exhibits some retarded ability to flap its wings.  These problems tended to be 
caused by two main factors.  Although most moths survived the insertion surgeries 
under healthy conditions, in many cases the implanted devices hindered the adult 
moths’ ability to pull themselves out from the cuticle during emergence.  The result 
was deformed wings clearly unable to be used for flight (see Fig. S3.3).  The second 
causes tended to be damage to the dorsolongitudinal flight muscles during 
implantation.  This limited the wing stroke which could be exerted during flight. 
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Table 3.1.  Comparison of survivability rate depending on the implantation date  
Survivability Data  7-8 days 1-2 days 
Survivability rate 93.75% 96.0% 
Flight-capable insect rate 12.5% 36.0% 
Sample size 32 50 
 
Based on these results, we found that the dorsal thorax is the best location for 
implantation, and 1 to 2 days prior to the insects’ emergence is the best timing for our 
current design as indicated in Table 3.1.  A movie illustrating the implantation surgery 
and developmental process is available as supplemental material (see 
chung_LOC_movie1.wmv) and Fig. 3.1d and 1e show a successfully emerged flight-
capable insect.  Paul et al. [30] presented results on inserting of silicon chips in the 
pupal stage with the flight-capable moths rate of 87.5%.  The devices implanted here 
were much larger and heavier devices resulting in survivability and flight-capable 
insect rates of 96% and 36%, respectively (Total sample size was 50).  As can be seen 
in Table 3.1, the survivability remains high in both cases suggesting that the 
implantation date does not critically affect the insects’ life.  The flight-capable rate 
however strongly depends on the insertion date with the latter implants yielding more 
flight ready insects.  The increase in flight ready rate observed for the later 
implantations is likely due to the fact that since more of the insect is formed, the 
likelihood of damaging the flight muscles is less than in the earlier stage implants.  
With the more developed insect’s the surgery could also be performed more precisely.  
At least part of the relatively low flight ready rate for the early stage implants is likely 
due to the relatively large size of the microfluidic device relative to that of the insect 
(as shown in Fig. 3.1).  We are currently working on designs which reduce the 
physiological footprint of the device. 
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Figure 3.3.  Injection procedure. (a) Prior to injection the insect was stimulated to 
gauge its baseline activity level. (b) Various chemicals were injected into the thorax to 
determine the dosage effects on the degree and length of insect temporary paralysis. 
(c) The moth paralyzes about a minute after injecting 5 µL of LGA. (d) In a successful 
test, after two to three hours, the moth recovers sufficiently to flap its wings.  
3.4.2 Characterization of physiological response to chemical injection 
Direct injection experiments were conducted to determine the optimal drug, dosage 
and delivery site for inducing the fastest physiological response and most complete but 
reversible impact on the level of observable insect activity.  Fig. 3.3 shows the 
injection procedure (see also chung_LOC_movie2.wmv).  The maximum capacity of 
our microfluidic chip was 15 µL and thus this was considered the upper limit for our 
injection volumes. 
For the species of interest here, there are three candidate injection sites: the head, 
thorax and abdomen.  The microfluidic device used here is larger than insect’s head 
and thus this was removed as a candidate.  Numerous injections were carried out at 
various positions along the abdomen.  It was generally observed that physiological 
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response times were slower and the required dosage was higher (approximately 5 
times) than for similar injections made in the thorax.  We expect that the rapid 
response was a result of the proximity of the central nervous system (CNS) and heart 
(aorta) to the thorax injection site.  As such the thorax was selected as the optimal 
injection/implantation site.  Once the injection site was localized a large number of 
different chemicals and dosages were tested including components of spider, wasp and 
scorpion venom, and some insecticides. 
The chemicals (L-Glutamic acid (LGA), L-Aspartate acid (LAA), γ-aminobutyric 
acid (GABA), Taurine and β-alanine) that were found to enable successful 
reanimation of the insect were the neurotransmitters that form the major/minor 
components of many spider and wasp venoms.  We selected these chemicals because 
they tended to reversibly paralyze the insect by acting on the neuronal receptors, 
neuronal ion channels or synaptic membrane [34].  For example, GABA  affects the 
insect’s chloride ion channel to induce immobilization and LGA/LAA influences the 
synaptic membrane, binding site and physiologic receptors to have paralysis [34, 35].  
The reversibility of the inhibition can be explained in terms of the effect of the venom 
on the site which does not damage or destruct the synaptic membranes (reversed by a 
membrane dilution-washing procedure) [35].  The excitation, therefore, decreases as 
time goes so that the reanimation of the activity can be found as we observed.  The 
insecticide Malathion was found to instantly kill the insect even in small doses and 
thus was not considered a useful candidate for further study. 
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Table 3.2.  List of chemicals injected into the thorax for immobilization  
Chemical Type 
(Concentration) 
Minimum Volume Remark 
LAA (11.11 M) > 5 µL Successful Reanimation 
LGA (5.9 M) > 5 µL Successful Reanimation 
GABA (10 M) > 20 µL Successful Reanimation 
Taurine (0.5 M) > 100 µL Successful Reanimation 
β-alanine (3 M) > 100 µL Successful Reanimation 
Malathion (1.23g/L) < 1 µL Insect did not Survive  
Atropine (N/A) N/A Insoluble in PBS 
Hadrurus arizonensis 
(N/A) 
N/A Insoluble in PBS 
 
Table 3.2 gives details of chemicals used, the minimum volume required to achieve 
paralysis and remarks on the ability of the insect to recover (all injections done in the 
thorax).  As can be seen, the approach most effective at retarding insect motion was a 
5 µL solutions of 5.9 M LGA and 11.1 M solution of LAA (both chemicals are 
excitatory transmitters at insect skeletal neuromuscular junctions [36]).  These 
concentrations represented the saturation concentrations for these chemicals.  In both 
cases within a minute of injection, the insect was immobilized for approximately 2 
hours, after which it regained its pre-injection activity level 
(chung_LOC_movie2.wmv). 
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Figure 3.4.  To illustrate the electrokinetic transport processes involved in the ejection 
stage, a finite element analysis of time-dependent species transport of the system is 
shown. Images show cut view of species concentration every 60 seconds up to 300 
seconds after the ejection process when 15 V is applied.  In the color scheme shown 
here, the blue contours represent lower concentrations and the red contours higher 
ones.Computed electric field lines in electroactive microwell  
3.4.3 Electrokinetic drug delivery device 
The microfluidic device structure used here is a modification of that presented by 
Chung et al. [26], which exploited the same electrochemical dissolution technique and 
electroactive ejection schemes.  In the first stage, an electric potential is applied 
between two electrode pads on top of the microchip serving to electrochemically 
dissolve the membrane.  To electrokinetically eject the contents from the reservoir, in 
the second stage a potential field is applied between one of the upper electrodes and 
that on the Pyrex bottom substrate.  As described in detail in Chung et al. [26], the 
technique is based on exploiting highly localized electrokinetic transport to rapidly 
exchange the contents of the reservoir with the external environment.   The use of 
electrokinetic transport allows for a significant reduction in the amount of time 
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required to eject the well contents over earlier diffusive transport based devices [37] 
(from hours to minutes), simplifies device design since only electrical components are 
required, and minimizes the rate amount of energy required per injection.  As 
illustrated in Fig. 3.2, compared to our previous design [26] this device had an 
additional Parylene coated on-board poly(dimethylsiloxane), PDMS, reservoir to 
increases the injectable volume from 100 nL to approximately 15 µL.  Due to water 
vapor permeability of the PDMS [38], Parylene was deposited on the sidewalls of the 
PDMS reservoir.  To improve the mechanical stability of the device, Pyrex glass was 
used as the bottom layer (as opposed to PDMS).  These latter two improvements 
resulted in significant improvements in device lifetime (earlier designs had a lifetime 
of approximately 5 days).  Long term tests of the device were not conducted however 
it was found that in all cases they remained operable for at least the expected lifetime 
of the insect. 
   To illustrate the electrokinetic transport processes involved in the ejection stage, a 
finite element model of the system was constructed and simulated using the COMSOL 
finite element package.  The computational domain used here matched exactly that 
shown in Fig. 3.2, comprising of both the well, PDMS reservoir and an exterior 
domain.  Details of the modeling procedures and general assumptions are available in 
earlier works [26] and thus here we focus on the specifics of this implementation.  Fig. 
3.4 shows a two dimensional cut view of the transient convection-diffusion solution 
during the ejection process.  To mimic the actual ejection process we consider pure 
electroosmotic flow.  From Fig. 3.4 it can be seen that the applied potential induces a 
strong electroosmotic flow dragging fluid from the external environment into the 
reservoir.  This then displaces the contents of the reservoir which is ejected through 
the middle of the outlet.  Note that although some of it remains for the entire duration 
of the ejection process, much of the contents are ejected in the early stages.  As we 
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will show in the following section the initial discharge in the first 90 seconds is 
sufficient to observe a response. 
 
Figure 3.5.  Microfluidically modulated insect activity (a) The overhanging boom 
supports the insect in midair allowing it to flap its wings unimpeded (b) Actuation of 
the drug delivery device occurs in two stages. In the first stage an electric potential is 
applied between two electrode pads on top of the microchip serving to 
electrochemically dissolve the membrane. To electrokinetically eject the contents from 
the reservoir, in the second stage a potential field is applied between one of the upper 
electrodes and that on the Pyrex bottom substrate. Due to the ejection of the drug (here 
LGA), the activity of the wing motion decreases. (c) Insect fully immobilized by LGA 
in 90 seconds after 2
nd
 stage command is issued. (d) After one hour and 20 minutes, 
the moth is again able to flap its wings.  
3.4.4 Demonstration of flight metabolism control using implanted microfluidics  
Based on the results of the insertion experiments, the microfluidic devices were 
implanted in M. sexta pupae, approximately 1 or 2 days before the adult insects were 
scheduled to emerge.  On-chip reservoirs were filled with one of three different 
chemicals, LGA, LAA, and phosphate buffered saline (PBS) buffer solution which 
served as a negative control.  Flight metabolism control experiments and the 
quantification which will be described below were conducted only on moths which 
were capable of flight after emergence.  A typical experiment is shown in Fig. 3.5, 
where as can be seen, the electrical leads from the device were connected to thin 
copper wires which lead to an overhanging boom supporting the insect in midair.  All 
insects received only one injection (no multiple injection experiments were conducted).  
When a dosage command was issued, the two stage injection process (described 
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above) was initiated.  We applied 15 V for 4 minutes and 20 V for 4 minutes for 
membrane dissolution and electrokinetic ejection stages, respectively.  For both LGA 
and LAA a dramatic reduction in the wing motion (i.e. rate and amplitude of flapping 
strokes) was observed, 90 seconds after the 2
nd
 stage command was issued.  No 
observable difference was found for the PBS ejection experiments.  In the negative 
control case the device was excised to visually confirm that it had been actuated.  
During the ejection process, the applied potentials may have lead to some ohmic heat 
generation which could have affected the potency of the chemicals used during the 
injection process.  Though we have not fully characterized this, we do not expect that 
this is significant since the results of the device and manual ejections yielded similar 
results.  After the discharging of the applied potential, the drug-induced 
immobilization lasted one hour and 20 minutes, after which the moths regained 
activity level (see chung_LOC_movie3.wmv).  Timescale for reanimation is much 
larger than that of immobilization because the insect regains its previous activity by 
natural recovery process.  To verify that the paralysis was not due to the applied 
potential, the same voltages were applied on a dummy chip.  As expected, no 
immobilization was noticed. 
3.4.5 Quantification of the metabolic rate 
 
To quantify the immobilization/reanimation process, metabolic rates were inferred 
from the Carbon Dioxide (CO2) output of the insects in a respirometry chamber.  
Details of the experiment are available elsewhere [39, 40] and here we just briefly 
provide an overview of the experimental procedure.  The moths were glued onto a 
narrow beam that allowed unencumbered wing flapping and leg movements.  To 
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stimulate a continuous flight response of the insect, a custom made mechanical 
agitator (chung_LOC_movie4.wmv) was placed inside of the sealed chamber.  In the 
experiment, dry, CO2 free air was pumped through the respirometry chamber at room 
temperature and all output gas passed through a carbon dioxide analyzer to measure 
the CO2 output.  Metabolic rate (and therefore CO2 output) is higher during flight or 
attempted flight relative to periods when the animal was quiescent in the respirometry 
chamber.[40]  To establish a baseline of the insect metabolic output at rest, the system 
was flushed until a stable CO2 level was recorded.  Following this the insect was 
mechanically stimulated as described above to initiate a flight response which was 
maintained until the CO2 output again reached an equilibrium level.  After 17 minutes 
of flight level activity, the membrane dissolution and ejection potentials were applied 
for approximately 10 minutes.  Note that we applied the electric potential for this long 
of a time period here in order to be able to accurately gauge its effect on the insect 
activity level. 
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Figure 3.6.  (a) Representative recording of CO2 emission from adult moth as a 
function of time when an implanted microfluidic device with 15 µL of 5.9 M LGA 
was injected. (Inset) After 22 hours, the insect was stimulate to fly for 25 minutes and 
it fully recovered its previous metabolic activity rate (b) Normalized metabolic rate 
comparing 5.9 M LGA (blue), 2.95 M LGA (black), 11.1 M LAA (green) and PBS 
buffer (red).  
As can be seen in Fig. 3.6a the metabolic rate drops off rapidly following the LGA 
(5.9 M) ejection.  The insect was stimulated for 10 seconds every 5 minutes until the 2 
hours mark with almost no activity observed (chung_LOC_movie5.wmv).  At 45 to 
47.5 minutes, to ensure the full immobilization, extremely strong perturbations were 
applied and the insect responded for a short time, approximately 1 minute, but 
returned to its quiescent state immediately afterwards.  To validate the reversibility of 
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the process, three hours and 22 hours after the initial ejection, the insect was again 
stimulated.  At 3 hours the insect was shown to recover 63.6% of its previous activity 
level (peak-to-peak value), and after 22 hours the moth fully recovered its previous 
level (see inset in Fig. 3.6a). 
Fig. 3.6b compares the result obtained for implanted devices containing different 
LGA doses (5.9 M from Fig. 3.6a and 2.95 M), LAA (11.1 M) and the negative 
control solution (PBS).  The additional experiments were conducted using the same 
methodology and drug volume as described above.  For more accurate comparison in 
this figure, we set time equals zero as the time when the device was actuated.  When a 
half concentration dose of LGA (2.95 M) was injected, the metabolic rate was dropped 
approximately 50%.  When the agitator was reengaged, the insect resumed flight but 
only at this reduced activity level.  The effect of LAA was similar to the full LGA 
dose, showing rapid immobilization and reanimation later as expected.  When the 
negative control was ejected the insect continued to exhibit a strong flight response 
until the agitator was disengaged at 20 minutes.  At 50 minutes the agitator was turned 
on again and the insect resumed full activity.  This result demonstrates that the flight 
response of the insect can be directly manipulated through dosage control. 
3.5 Summary and conclusion 
We demonstrated here a method of exerting chemical control over insect flight 
activity, exploiting the use of immature stage implanted microfluidics to reversibly 
control the rate of metabolic output.  Such a system could be the first step towards the 
development of an artificial insect nervous system where the controlled release of 
inhibitory or excitatory neurotransmitters could be accomplished in response to 
external stimuli.  Extension of this work to include a multi-reservoir microfluidic 
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device for short timescale release control (i.e. off/on/off/on) would enable a new 
paradigm for insect flight control alongside established electrical techniques. 
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CHAPTER 4 
A ROBUST, ELECTROCHEMICALLY DRIVEN MICROWELL DRUG 
DELIVERY SYSTEM FOR CONTROLLED VASOPRESSIN RELEASE
*
 
4.1 Abstract 
Micro-electro-mechanical-system (MEMS) based implantable drug delivery 
devices represent a promising approach to achieving more precise dosing, faster 
release and better localization of therapeutic compounds than is possible with existing 
technology.  Despite recent advancements, there remain challenges in being able to 
build systems that enable active control over the dose rate and release time, in a robust, 
low power but simple to fabricate package.  Here we demonstrate an implantable 
microreservoir device that enables delivery of dose volumes as high as 15 µl using an 
electrochemically based transport mechanism.  This approach allows for a significant 
reduction in the amount of time required for drug delivery as well as reducing the 
dependence on the external physiological conditions.  We present the overall design, 
operating principle and construction of the device, and experimental results showing 
the volume transport rate as a function of the strength of the applied electric field.  The 
concentration profile vs. time, the power consumption, and ejection efficiency are also 
investigated.  To demonstrate the medical utility of the device we also characterize the 
in-vitro release of vasopressin.  
 
 
 
 
                                                 
*
Re-printed by kind permission from Springer Science Business Media with permission from Aram J. 
Chung, Yun Suk Huh and David Erickson, “A robust, electrochemically driven microwell drug delivery 
system for controlled vasopressin release”, Biomedical Microdevices, 11, 861-867 (2010) DOI: 
10.1007/s10544-009-9303-y 
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4.2 Introduction 
Vasopressin (Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2) is a peptide hormone 
synthesized in the hypothalamus and stored/secreted in the posterior pituitary.  
Administration of vasopressin induces changes in the arterial blood pressure by 
increasing the resistance of the peripheral vessels [1].  In healthy individuals the effect 
is often negligible; however it can become a crucial compensatory mechanism for 
restoring blood pressure during hemorrhagic shock [1, 2].  At present, the primary 
treatment for hemorrhagic shock is fluid replacement; however this is sub-optimal [3], 
since it may worsen the patient’s condition by dilution of the coagulant [4-7].  As an 
alternative therapy, Morales et al. [8] reported a set of canine experiments where 
vasopressin levels showed a marked increase at the onset of blood loss followed by a 
fall to well below the normal physiological level.  Voelckel et al. [9] and Lindner et al. 
[10] demonstrated that the administration of vasopressin improved the survival rate in 
porcine cases and more recently Krismer et al. [11] reported for human as well.  
Excessive doses of vasopressin however have been known to induce injuries to the 
gastrointestinal tract, skin, myocardium and liver [12, 13].  Administration of 
vasopressin therefore represents a potential life-saving treatment for hemorrhagic 
shock upon its replenishment but it should be delivered rapidly and with precise 
timing to avoid side effects. 
In this work, we present an implantable silicon micro-reservoir device that enables 
delivery of dose volumes as high as 15 µl using a more robust electrochemical 
transport mechanism.  Briefly, the delivery mechanism is based on the use of an 
electrolytic reaction driven between the capping membrane and another electrode 
located inside the reservoir.  When the reaction is initiated, gold dissolution causes a 
gradual loss of the mechanical integrity of the capping membrane which eventually 
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ruptures and opens.  Gas released during the electrolytic reaction builds up the 
pressure in the reservoir which then forces the contents out of the well, independent of 
the external environmental conditions.  We demonstrate herein that this approach also 
allows for a significant reduction in the amount of time required to eject well contents 
over earlier devices.  In this paper, we present the overall design, operation principle 
and construction of the device, and experimental results showing the volume transport 
rate as a function of the strength of the applied electric field.  The concentration 
profile vs. time, the power consumption, and ejection efficiency are also investigated.  
To demonstrate the medical utility of the device we also characterize the in-vitro 
release of vasopressin.   
 
Figure 4.1.  (A) Schematic representative of the electrochemically enhanced 
microfluidic drug delivery device developed here. The device measures 4.4 x 2.3 x 22 
mm (w x h x l). (B) Magnified view of microchip from above looking at the region 
near the membrane. Black square box represents the capping gold membrane. (C) 
Magnified view near fabricated microwell. (D) Microchip assembly: (1) an upper 
silicon based structure (2) PDMS macro-reservoir (3) gold electrode on top of Pyrex 
substrate. All layers are bonded together by plasma oxidation.  
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4.3 Materials and methods 
4.3.1 Device fabrication and assembly  
The microfluidic device structure used here is a modification of that presented by 
Chung et al. [14] and used to control the flight metabolic output of insects in Chung 
and Erickson [15].  A 3D schematic of the device is shown in Fig. 4.1.  All fabrication 
procedures described below are based on standard MEMS processes [16].  Briefly, 
starting with (100) silicon wafer, silicon nitride is deposited on both sides of the wafer 
and the backside was etched to define the bottom of a microwell reservoir.  
Subsequently, gold electrodes were evaporated using an image reversal contact 
lithography process, and then a polyimide dielectric layer was spun on and etched so 
as to expose the electrodes and isolate the leads.  The pyramidal microwells were then 
defined by immersing the wafer in potassium hydroxide (Fig. 4.1C) and the remaining 
silicon nitride underneath the gold membrane was removed by reactive ion etching.  
To create the high volume macro-reservoir a scalpel patterned PDMS spacer was 
placed between the upper silicon chip and the lower Pyrex support.  The approach is 
based on that developed by Li et al. [17] who used a similar approach to create a 
Pyrex macro-reservoir.  The use of PDMS here however allows us to simplify device 
fabrication (by eliminating HF based glass etching or machining steps) and facilitate 
assembly (by eliminating wafer bonding steps).  Finally the electrode pads and leads 
on the bottom Pyrex layer were fabricated through gold deposition and standard lift-
off processing.  Note that the biocompatibility of all the materials used here have been 
thoroughly investigated by others in a series of recent studies [18-21]. 
To assemble the device the upper (silicon), middle (PDMS), and bottom (Pyrex) 
substrates were air plasma treated, placed in conformal contact and then stored in an 
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80°C oven overnight.  After this bounding process was complete, the macro-reservoir 
was filled with the desired chemicals using microsyringe (1705TLL, Hamilton, NV, 
USA) through a prefabricated side slit.  The slit was then sealed with biocompatible 
wax (Butler GUM, Sunstar, IL, USA) as illustrated in Fig. 4.1A.  After this, the 
electrode leads were connected to thin copper wires using silver conductive epoxy 
(M.G. Chemicals, Surrey, BC, Canada).  As shown in our recent work [15], for long 
term stability the PDMS surface must be coated with Parylene (or a similar 
hydrophobic material [22]) in order to minimize fluid loss into the water permeable 
PDMS substrate.  In addition, to minimize the physiological response upon 
implantation [18, 23], a surface modification, for example, PEG (Poly-ethylene 
glycol) should be applied as we have done in the past [15].  Comprehensive, long term 
tests of the device were not conducted here however it was found that in all cases the 
devices remained operable for at least a week after surface modifications. 
4.3.2 Vasopressin transport: visualization and quantification 
To visualize and quantify the chemical release, FITC tagged vasopressin was used.  
A fluorescein labeling kit and the vasopressin (Arg8-vasopressin) were purchased 
from Dojindo (Rockville, MD, USA) and Sigma-Aldrich (St. Louis, MO, USA), 
respectively.  FITC was dissolved in 10 µl dimethyl sulfoxide (DMSO) and 8 µl of this 
solution was well mixed with 100 µl of reaction buffer.  After this, the sample was 
incubated at 37°C for 10 minutes and 100 µl of 100 mM phosphate buffered saline 
(PBS) was added to a filtration tube and centrifuged.  Since the molecular weight of 
the vasopressin is relatively small (~1kD), we used Microsep™ centrifugal devices 
(Pall Corporation, East Hills, NY, USA).  The tube was centrifuged at 8000 rpm for 12 
hours at 4°C.  Lastly, 200 µl PBS was added to the FITC-vasopressin conjugation and 
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the final mixture was transferred to a 0.5 ml tube and stored at 4°C.  The FITC-
vasopressin conjugation was diluted to the appropriate concentrations described below 
in 100 mM PBS containing 0.145 M of chloride ions (pH 7.4) which was reasonably 
close to the chloride concentration in human blood (Fitzsimons and Sendroy 1961). 
The transport of the fluorescein was recorded using Unibrain Fire-i
TM
 software and a 
Sony XCD-X710 (Tokyo, Japan) camera. 
The amount of vassopressin ejected from the devices was quantified via a protein 
assay using the BCA™ Protein Assay Kit (Pierce, Rockford, IL, USA).  The assays 
were performed using a 96-well plate (Corning, Corning, NY, USA), and absorbance 
was measured at 562 nm by SPECTRAmax 384 (Molecular Devices, Sunnyvale, CA, 
USA).  The vasopressin concentration was calculated from the bovine serum albumin 
(BSA) standard curve.  
 
Figure 4.2.  Scheme describing the operational stages of the electrochemically driven 
microfluidic drug delivery device (not to scale). (A) The electric potential is applied 
between top and bottom electrodes and current flows through the reservoir 
independent of the surrounding environment. (B) Two main electrochemical reactions 
occur: dissolution of the gold membrane and electrolysis or water resulting in gas 
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release. (C) The generated microbubbles propel well contents out. (D) The reaction 
continues until fluid transport stops.  
4.3.3 Device design and operation principle 
A diagram of the device operation is shown in Fig. 4.2.  The PDMS reservoir and 
microwell contain approximately 15 µl of 0.05 g/l vasopressin for release.  When drug 
release is desired, an electrical potential is applied between upper and lower 
electrodes, as shown in Fig. 4.1D, resulting in two electrochemical reactions which 
affect the ejection process.  First, the presence of a small amount of chloride ions in 
the buffer solution creates a water-soluble chlorogold complex from the gold 
membrane [24] (this was similarly demonstrated by Santini et al. [25]).  This results in 
a gradual loss of the mechanical integrity of the membrane (due to dissolution of the 
gold) which eventually ruptures, exposing the contents to the external environment.  
Simultaneously, the two electrodes also serve as an anode and cathode for electrolysis 
of water.  Gas released during this reaction results in an increased pressure in the 
reservoir which pushes the liquid contents out through the dissolved membrane.  More 
details on the electrochemical reaction are available in the supplemental material.  In 
all cases, a Keithley 236 Source-Measure Unit (Cleveland, OH) was used to apply 
these potentials and to measure the current load. 
4.4 Results and discussions 
4.4.1 Electrochemical driven ejection 
The electrochemical transport mechanism was demonstrated for two different 
interface conditions: the first being for the drugs ejected directly into the air and the 
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other is the chemicals ejects into a fluid solution surrounding the gold membrane.  As 
mentioned in the introduction, one of the most significant limitations to the 
development of implantable drug delivery devices is the uncertain physiological 
conditions that will be faced upon implantation.  Many of the passive devices 
discussed above are compatible with specific solution-phase environmental conditions 
(e.g. polymer based biodegradable systems) and thus suffer from significant 
performance degradation due to, for example, biofouling [18, 23].  One of the major 
advantages of the electrochemical reaction based device developed here, is that allows 
us to build the pressure up in the reservoir and burst into the external environment, 
independent of the surrounding conditions. 
 
Figure 4.3.  Illustration showing ejection of vasopressin with 720 nm fluorescent 
polystyrene microsphere particles from a reservoir. (A) Before applying potential. (B) 
Picture of a sample device after ejection into air for five minutes (no initial covering 
fluid) (C) Case 1: Ejection into the air—frame taken one minute after application of 12 
V potential (D) Case 2: Ejection into PBS buffer—frame taken one minute after 
application of 12 V potential.  The red arrow shows small bubbles release from the 
well during the ejection process, next to one large bubble in the center region.  
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Fig. 4.3 shows time lapse images illustrative of the electrochemical transport of 15 
µl of 0.05 g/l vasopressin for the case of an applied potential of 12 V.  In order to 
clearly illustrate the dispersion pattern, we added 720 nm fluorescent flow tracers to 
FITC-vasopressin conjugation (see supplemental Movies 4.1 and 4.2).  On average 
approximately 23 seconds after application of the potential the stored contents begin to 
be ejected from the reservoir.  Figure 4.3C shows when the contents are ejected into 
air and Fig. 4.3D shows the case for ejection into PBS buffer. 
 
Figure 4.4.  (A) Release rate of vasopressin from sample devices as a function of time 
for different voltages. (B) Concentration profile of vasopressin calculated from BCA 
protein assay. We set time equals zero as the time when the electrochemical reactions 
are actuated.  
To characterize the ejection volume flow rate as a function applied potential, the 
dispersion pattern of the fluorescent microspheres was recorded as a function of time.  
By placing a coverslip at a controlled distance above the ejection point the area of the 
dispersion could be related to an ejected volume using a simple flat cylinder model.  
Images were then analyzed and processed using ImageJ (National Institutes of Health, 
http://rsb.info.nih.gov/ij/) and a self-written MATLAB routine (Mathworks, Natick, 
MA, USA).  The results of these experiments are shown in Fig. 4.4A.  In all cases the 
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advancing fluid front was traced to a distance of 1 mm, limited by the field of view of 
the microscope.  As can be seen there exists a strong dependence of ejected volume on 
the applied potential.  For the first 25 seconds, the maximum (12 V) and minimum (8 
V) volumetric rates were 4.19 µl/min and 0.460 µl/min, respectively.  As such in 
addition to reducing the overall ejection time (over passive devices), the 
electrochemical technique also provides a method for controllably modulating the 
delivery rate through simple adjustment of the applied potential.  By modulating the 
applied voltage the device could also be adapted to pulsatile delivery [14]. 
4.4.2 Vasopressin release 
Time dependent dose profiles were also characterized using FITC-labeled 
vasopressin as described above.  To perform the experiments a control volume of 15 
µl of 100 mM PBS was added on top of the membrane and the vasopressin ejection 
process was enacted for a prescribed length of time.  After terminating the ejection 
process, 1 µl of sample was extracted from the covering drop (after gentle mixing to 
ensure homogeneity of the mixture) and dispensed into a 96-well plate for absorbance 
measurements.  The concentration of vasopressin in the drop was determined using the 
technique described above and the results are plotted in Fig. 4.4B.  For all 
experiments, time equals zero was set as the point when the electrochemical reaction 
was initiated.  Analogous to the results presented earlier, Fig. 4.4B also illustrates how 
increasing the applied potential results in the system reaching the plateau 
concentration much more rapidly.  Note that a relatively low concentration of 
vasopressin was used in this experiment in order to be compatible with the BCA 
protein assay.  With the current volume of 15 µl, the device is able to deliver 
maximum of 120 IU (Arg8-vasopressin contains approximately 400 IU/mg [26] and 
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has a solubility of 20 mg/ml).   Krismer et al. [11] reported a set of human cases that 
where dosages of 100 to 160 IU vasopressin helped to restore spontaneous circulation 
with sinus rhythm in 2 minutes.   Importantly, the 120 IU limitation of the existing 
device can be circumvented by parallel integration of devices onto a single chip.  This 
would make it possible to deliver much larger dosages. 
Although the focus of this paper is on device design and transport characterization, 
it is important to briefly discuss the stability of the vasopressin following the 
electrochemical ejection process.  To assess this here we have performed a number of 
additional mass spectroscopy experiments using MALDI-TOF/TOF (4700 Proteomics 
Analyzer, Applied Biosystems, Foster City, CA, USA).  Samples were tested after 
different electrolytic ejection times using 12 V as the driving voltage, since this 
represented the harshest conditions we considered in this paper.  The details and 
results of these experiments are presented in the supplemental material (Fig. S4.1 and 
associated text) however strong vasopressin peaks (at ~1.085kD) were still observed 
in the ejected contents after continuous application of the driving potential for 5 
minutes.  When compared with the control sample however two additional smaller 
peaks were also observed at 1.101 kD and 1.117 kD.  These two extra peaks are likely 
oxidation products, suggesting that the electrochemical reaction did cause some degree 
of degradation to the vasopressin.  We are continuing to investigate this observation 
and hope to better quantify the degradation in the future. 
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Figure 4.5.  Representative power load during ejection process for the 12 V case. The 
line through the data points in this figure represents an exponential best fit. Error bars 
are not shown since they were smaller than the data marks.  
4.4.3 Power consumption 
To determine the power requirements for both the membrane dissolution and 
electrochemical ejection stages a Keithley 236 Source-Measure Unit was used to 
monitor the current load.  Figure 4.5 plots a representative case at 12 V where the 
instantaneous total power consumption was obtained by multiplying the measured 
current by the applied potential.  As can be seen, the power consumption decreases 
with time, reaching a plateau of around 0.130 mW after 240 seconds.  For the 12 V 
case the maximum power load was approximately 5 mW, however this dropped to 
around 0.9 mW for the 8 V case.  This could be further reduced by decreasing the 
thickness of the PDMS layer, thereby decreasing the distance over which fluid 
transport must occur and with that the required voltage.  Previous studies on similar 
dose control systems have shown that the electrostatic micropump [27], thermo-
pneumatic [28], bubble-type planar micropump [29], and ionic conductive polymer 
film micropump [30] techniques require 1 mW with 200 V, 450 mW with 15 V, 18 
mW with 10 V, 1000 mW with 40 V and 180 mW with 1.5 V, respectively.  In 
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comparison the method represent a good combination of both low voltage 
requirements and low power consumption. 
 
Figure 4.6.  Release results: total amount of vasopressin recovered over 5 minute from 
each reservoir when 20 V is applied. 
4.4.4 Ejection efficiency  
The efficiency with which the contents were ejected from the well was quantified 
by comparing the ratio of the volume loaded into the reservoir with that recovered 
after the ejection process.  In these experiments the recovered volume was calculated 
in the same manner described in section 3.2.  The cumulative amounts of FITC-
vasopressin recovered per release for each trial are shown in Fig. 4.6.  The average 
amount recovered from 10 reservoirs over 5 minutes when 20 V was applied was 
50.3%.  The standard deviation among the 10 trials was 6.6%.  We expect that this 
ejection efficiency could be increased by decreasing the thickness of the PDMS layer.  
This would however result in a lower total dose volume. 
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4.5 Conclusion 
We have demonstrated here an electrochemically driven, implantable, low power 
and rate controllable drug delivery device.  This approach serves to actively propel the 
drugs from within a sealed reservoir to the external environment using a combination 
of electrolytic and gold dissolution reactions induced by the application of a voltage 
between the top and bottom of the device.  The contents dispense rate, concentration 
profile and power consumption of the device were characterized experimentally.  An 
ejection rate as high as 4.19 µl/min was recorded at a maximum power consumption of 
roughly 5 mW. 
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CHAPTER 5 
HYBRID TECHNIQUES FOR MODULATING INSECT FLIGHT ACTIVITY 
AND LONGEVITY
*
 
5.1 Abstract 
Insect microairvehicles represent a promising alternative to traditional small scale 
aircraft because they combine the enhanced energy storage and maneuverability of 
living insects with the controllability offered by microelectromechanical systems. 
These systems have been previously demonstrated, usually using either electrical (with 
implanted electrodes) or chemical (with implanted microfluidics) control schemes, but 
to date little work has been done on the creation of hybrid systems that use both these 
two methods simultaneously.   In this paper we develop an integrated microsystem 
that uses both chemical and electrical methods to modulate the flight activity of 
Manduca sexta moths. The electrical component of the system initiates and maintains 
flight by applying electrical pulses to an antenna lobe and an implanted drug delivery 
component modulates flight output power by administering a neurotransmitter dose to 
the central nervous system.  Flight longevity results acquired with this system are 
compared with those obtained from direct mechanical stimulation. We demonstrate 
that the electrical stimulation provides as much as 35-fold enhancement in flight 
duration with respect to mechanical agitation and that a 50% mean flight power output 
reduction can be achieved with the proper neurotransmitter dose.  
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5.2 Introduction 
The downscaling of traditional air vehicles [1] presents severe challenges. Most 
prominently, wing size reduction compromises vehicle aerodynamics and makes a 
flapping type motion necessary in order to lift an aircraft body. One way this problem 
has been addressed in the past is by using microelectromechanical system (MEMS) 
technology [2] to generate small flying robotic systems with biomimetic [3] 
characteristics.  An example of this is the flapping Diptera robots reported by Wood et 
al. [4]. Such systems experience long term power constrains since storage capacity 
scales with the volume of the carrier. Living insects, on the other hand, are 
aerodynamically efficient and can offer superior long term flight endurance [5, 6] with 
flight times reaching as long as several days.  Attempts to directly train insects to 
perform useful flight maneuvers have proved extremely challenging [7].   
One way to address this dichotomy is through the development of systems that take 
advantage of the energy storage and flight capabilities of living insects with the 
precise control enabled by modern MEMS technology. These systems are of 
significant technological interest [8] due to their applicability to remote surveillance 
[9] and power harvesting [10, 11]. The dominant paradigm for insect flight 
manipulation is based on electrical control of neuromuscular activity [12]. 
Aerodynamic operations including liftoff, yaw control and landing have been 
demonstrated by Bozkurt et al. [13] in Manduca sexta moths. Similar operations were 
performed by Sato et al. [14, 15] with Cotinis texana beetles using wireless DC pulses 
applied to neuromuscular centers. Tsang et al. [16] demonstrated flight steering in 
Manduca sextae by controlling their abdominal orientation using a flexible electrode 
ring attached to the nerve cord. Microsystems which use chemical control have also 
been used. For example, Chung and Erickson [17] induced a reversible chemical 
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paralysis in a tethered Manduca sexta moth via an implantable microfluidic chip that 
released various neurotransmitter solutions. 
A system that harnesses the maneuverability offered by the electrical approach with 
the speed control and physiological access enabled by chemistry could increase the 
number of achievable flight routines. Towards this end, in this paper we demonstrate 
the integration of chemical and electrical methods for modulating the flight activity of 
Manduca sexta moths. To analyze the flight behavior we performed a series of 
tethered experiments which measure changes in flight output power for different 
neurotransmitter doses subject to continuous electrical pulse stimulation. The results 
are used to create a wireless hybrid system that enables tetherless hybrid flight control 
and compared with direct mechanical stimulation which is used as a baseline.  We 
focus here on developing the hybrid flight mechanism rather than device 
miniaturization as this has already been demonstrated [13, 14, 16].  
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Figure 5.1.  Combined electrical and chemical modulation of insect flight power and 
speed. (A) Experimental setup showing moth attached to hinged solid beam (see 
Movie S5.1). (B) Flight angle before (red) and after 0.5 M L-Glutamic Acid (LGA) 
injection. (C) Flight velocity and thrust response following injection of different 
concentrations of LGA. (D) Flight power output following injection of different 
concentrations of LGA  
5.3 Results and discussion 
5.3.1 Flight power/speed analysis of combined chemical and electrical 
modalities  
In this first section we analyze the flight response of Manduca sextae to 
simultaneous chemical and electrical stimulation. To characterize thrust, speed and 
flight power moths were tethered to a hinged beam as shown in Fig. 5.1A. The 
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displacement angle (θ) was measured and analyzed[18] for moths that had been 
injected with solutions containing different concentrations of L-Glutamic acid (LGA) 
neurotransmitters (refer to Materials and Methods section below for more details). 
After injection, insects are stimulated into flight by supplying a sequence of 3 V, 25 
Hz DC pulses with a 50% duty cycle for 0.5 seconds followed by a one second pause. 
These pulses are applied between an electrode implanted near the antennal lobe and a 
common ground implanted in the dorsal thorax (Fig. 5.1A). These electrical pulses 
tended to stun the moth when initially applied, but resulted in strong flight behavior 
during the off cycle (see Movie S5.1). The  electrical stimulation can maintain 
continuous flight activity and the role of the injected chemical is to throttle flight 
speed by overstimulating the moth’s central nervous system[19]. Figure 5.1B shows a 
sample experiment following manual injection of 10 µl of 0.5 M LGA solution.   
To translate angle data into flight thrust, the simple moment balance model shown 
below was used, the details of which are provided in the supplementary information. 
tan ( / 2 )straw mothF g m mθ= +     (2.1) 
The supplementary information also explains how the thrust data can also be 
converted to velocity and power output differences. The thrust and velocity 
characteristics of moths subjected to different concentrations of LGA are shown in 
Fig. 5.1C. For the phosphate buffered saline (PBS) injection (negative control, 0% 
LGA) one minute after injection the thrust and velocity values are greater than those 
obtained prior to injection (denoted with the subscript “ref” in Figs. 5.1C and D). This 
is because inserting and withdrawing of the needle irritates the insects, and PBS does 
not drastically reduce flight capacity. For 1 M and 0.5 M LGA solutions, moths fly on 
average at 22% below their pre-injection flight speed (Fig.5.1C) for the first twenty 
minutes, with a gradual speed increase as the solution is metabolized. The flight power 
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output is shown in Fig. 5.1D. 0.5 M and 1 M LGA solutions result in rapid drop in 
output power which is regained to approximately 50% of the reference value within 10 
minutes. Those subjected to 5 M doses regain half of their activity 1.5 hours later. 
Long-term reduction in flight speed can be useful for applications such as remote 
surveillance [9]. It is worth noting that the recovery time is approximately 2-fold 
quicker compared to our previous work [17] where no electrical stimulation was used. 
In addition to the functions demonstrated here, chemical injection could also offer 
additional capabilities. For example, different chemicals have been used to promote 
growth [20, 21] or to induce characteristic flight patterns [22, 23] in Manduca sexta 
moths. 
 
Figure 5.2.  Wireless hybrid system for Manduca sexta flight control. (A) Schematic 
of moth showing both microfluidic chip, which is implanted in dorsal thorax, and the 
copper wire used for electrical stimulation, implanted in the antennal lobe (see Movie 
S5.2 for interactive version). (B) Insect showing implanted microfluidic chip and 
electrode. (C) 3D Computed Tomography (CT) image of fluidic chip implanted into 
dorsal thorax (also available as Movie S5.4). (D) Fluidic chip subcomponent assembly 
in exploded view and (E) actual fluidic chip. (F) Time lapse of images showing 
sample ejection sequence of 5 M L-Glutamic acid (LGA) solution into 10 mM PBS 
solution (see Movie S5.3).  
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5.3.2 Wireless hybrid system for insect flight modulation  
We now construct and test a wireless system based on the electrical and chemical 
hybrid technique demonstrated above. The full scale system is shown in Fig. 5.2B and 
illustrated schematically in Fig. 5.2A for clarity. Movie S5.2 is an animated video that 
illustrates the hybrid stimulation process. For the integrated system, a commercial 
wireless microcontroller (TI eZ430) with multiple independent electrical output ports 
is used to trigger both the electrical stimuli and the actuation of the microfluidic chip 
(see Fig. S5.1). The microfluidic chip (Figs. 5.2D-F) is implanted in the moth’s dorsal 
thorax and uses an electrochemical pumping procedure that was previously 
demonstrated by Chung et al. [24] Briefly, chlorine ions in the buffer react with the 
capping gold membrane on top of the fluidic chip thereby dissolving it. In addition, 
water electrolysis releases gas which builds up the pressure in the enclosed chamber, 
leading to mechanical failure of the capping membrane and release of the contents. 
The microcontroller has a standard output of 3 V, so the anode of the microfluidic chip 
was connected to a custom designed 34 V DC to DC converter to increase the reaction 
rate.  The bottom electrode of the fluidic chip is connected to the universal ground.  
This version of the chip is 4 times smaller than its predecessor[24] while still capable 
of carrying the same volumetric payload. This was achieved by reducing the 
lithographic pattern dimensions as well as implementing a custom 3D printed acrylic 
channel to hold the chemical payload (see the Materials and Methods for more details 
on fabrication). Figure 5.2F is a time-lapse image showing the fluidic ejection of 5 M 
LGA solution (also see Movie S5.3). The enclosed solution bursts out of the device at 
a speed of nearly 10 cm/s and the majority of the fluidic contents are ejected by the 80 
second mark. Electrical stimulation was achieved by implanting a thin wire electrode 
in the moth’s antennal lobe (Fig. 5.2A and 2B) and connecting it to a secondary output 
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port of the wireless microcontroller. To facilitate our experiments, we use a helium 
balloon to support the additional weight of the electronics, but further miniaturization 
of the electrical system is possible and has been already demonstrated [14, 16, 25]. To 
assess the invasiveness of our microfluidic and electrical implants, Fig. 5.2C and 
Movie S5.4 show a 3D CT scan following implantation. We note that the chip 
penetrated about 3 mm into the thorax, bringing the chemical payload close to both the 
central nervous system and the main circulatory system for effective drug dispersal.  
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Figure 5.3.  Wireless hybrid flight operation and flight tracking. (A) Moth at rest. (B) 
Electrically stimulated take-off. (C) Time lapse images showing moth subjected to 
electrical stimulation followed by chemically induced paralysis (D) Two 
representative cases of insect trajectories where the red bands denote flight under 
electrical stimulation, green during the drug delivery stage and blue during the 
deceleration due to chemical overstimulation. (E) Vertical displacement and speed as a 
function of time. Insects speed up during electrical stimulation (red), are subjected to 
the chemical release (green) and decelerate (blue) due to chemical overstimulation 
(see Movie S5.5). 
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The operation and characterization of the system is shown in Fig. 5.3 and in Movie 
S5.5. The insect is brought from rest (Fig. 5.3A) into take-off (Fig. 5.3B) by supplying 
the same pulse sequence used in Figs. 5.1 and 2 and in Movie S5.1. After 30 seconds 
of sustained flight (Fig. 5.3C), the microfluidic chip was actuated, releasing the 5 M 
solution of LGA. The insect responds by first decelerating for about 20 seconds until it 
reaches full paralysis (Fig. 5.3C). The DC pulse routine was suspended during 
chemical release to prohibit interference between the two signals but resumed 
immediately after dosing was complete. To track the moth’s displacement and flight 
speed changes during flight, we used an in-door VICON tracking system. Two 
representative flight trajectories of full hybrid tests are presented in Fig. 5.3D, 
illustrating the three stages of flight: The red region denotes sustained flight under 
electrical stimulation (average flight speed 10 cm/s), followed by the drug delivery 
stage shown in green which captures the transition from stimulation to deceleration, 
and finally deceleration (blue) due to chemical overstimulation. The time to reach the 
onset of paralysis from the chemical ejection is within 5 seconds for both cases. Fig. 
5.3E shows the vertical displacement and its corresponding speed as a function of 
time. Both trends in Fig. 5.3E also show how the moths reach a standstill once they hit 
the ground. 
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Figure 5.4.  Comparison of mechanical and electrical flight duration enhancement 
techniques. (see Movies S5.1 and S5.6 for electrical and mechanical stimulation 
respectively) (A) Mechanical stimulation setup showing the moth prompted into flight 
by spinning a cotton swab on its head. (Inset) Moth unresponsive to long period of 
mechanical stimulation. (B) Comparison of electrical and mechanical enhancements in 
flight endurance showing both high and low electrical response groups. 
5.3.3 Comparison of electrical and mechanical flight longevity enhancement 
modalities  
In nature Manduca sexta moths tend to fly sporadically, a few times a day and in a 
manner that is very sensitive to the environmental conditions [26]. In practice it 
becomes necessary then to override their native behavior to achieve predictable flight 
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duration. Previously we demonstrated that direct mechanical stimulation can also be 
used to enhance flight longevity [17]. Although it is more difficult to construct an 
insect portable mechanical stimulation system, than it is for the electrical and chemical 
techniques demonstrated above, it is worthwhile to quantitatively determine which 
stimulation technique is better at promoting flight longevity. 
The results of our experiments comparing flight longevity for these modalities are 
shown in Fig. 5.4 and Movies S5.1 and S5.6. Mechanical stimulation experiments 
were conducted without tampering with moth internal physiology (which does occur 
with both electrical and chemical implants), by rubbing a spinning cotton swab on the 
moth’s head as shown in Fig. 5.4A and Movie S5.6. The cotton swab is attached to a 
pulsed DC motor and operates at the same frequency and duty cycle as that of the 
electrical stimulation experiments described above. The criterion used in these 
experiments is that 10 seconds of no flapping activity is considered as a full stop and 
the end of a test. Moths subjected to mechanical stimulation flew for an average of 5 
minutes as shown in Fig. 5.4B. For electrical stimulation, data was collected using a 
similar apparatus to that shown in Fig. 5.1. It was observed that these insects 
responded in a bimodal way with one group tending to fly continuously for close to 3 
hours on average and the other which flew for 17 minutes on average. The reason for 
this bimodal response is not known however it was clear that the low flight endurance 
group were much more rapid to adapt to the presence of electrical stimulation. When 
compared to the mechanically stimulated group, the high flight endurance group 
exhibited a 35-fold enhancement in flight duration. 
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5.4 Materials and methods 
5.4.1 Microfabrication 
The drug delivery system consists of three subcomponents. The first is a silicon 
layer containing a microwell with a suspended upper electrode through which fluids 
are ejected, a 3D printed acrylic channel coated with Parylene which contains the 
dose, and a bottom gold coated Pyrex substrate which serves as the counter electrode. 
The top silicon component was devised using the method established by Chung and 
Erickson [24], in which LPCVD silicon nitride is deposited on both sides of a <100> 
n-doped silicon wafer. The backside was patterned to define the well location, 
followed by gold deposition on the top side. The wells were then etched by immersing 
the wafer in KOH overnight and the remaining silicon nitride underneath the gold 
membrane was removed through reactive ion etching. This left a 100 µm by 100 µm 
square suspended gold membrane. A photoactive polyimide layer was spun and 
patterned on the top of the device to reduce electrical contact outside of the suspended 
gold membrane. One millimeter tall acrylic channels were defined and cleaned with a 
NaOH solution, followed by a Parylene deposition to ensure impermeability to water. 
The three subcomponents were then assembled and sealed using Loctite 454. The 
assembled device was then subjected to oxygen plasma cleaning, followed by fluidic 
loading from the backside and sealing using wax. 
5.4.2 Implantation process 
The microfluidic chips were implanted in adult moths 2 days after emerging from 
the pupal stage. Prior to the surgery, the moths were placed on an ice platform for 
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approximately 10 minutes to lower their internal body temperature and to minimize 
movement. With a sterilized scalpel, a portion of the dorsal exoskeleton and body skin 
were removed and the chip was placed 3 mm into the thorax near the dorso-
longitudinal flight muscles. After gently inserting the device into the thorax, the 
wound was sealed using Loctite 454. This step was followed by the thin electrode 
implantation, which is gently inserted next to antennal lobe and sealed with the same 
biocompatible glue. 
5.4.3 Displacement angle measurement and analysis 
A thin wire leash was used to tether the moths head and thorax to the swinging arm 
during the image tracking experiments. 10 µl solution volumes were used for all 
injections. The displacement angle was evaluated using a customized MATLAB code 
based on Hedrick et al.’s [18] previous work. To track the insects’ displacement in 3D 
tetherless flight, a reverse GPS system employing 24 VICON cameras was used to 
track IR reflecting balls attached to the helium balloon.  All relevant animal care and 
use guidelines were followed in this study.  
5.5 Conclusion 
In summary, here we have demonstrated the use of simultaneous chemical and 
electrical modalities for modulating the flight activity of Manduca sexta moths. The 
optimal hybrid stimulation conditions were determined through series of tethered 
experiments and implemented on a wireless insect-borne system.  The results were 
quantitatively analyzed by comparing them with baseline measurements using 
mechanical stimulation. It was shown that electrical stimulation can result in as much 
 107 
 
as 35-fold improvement (on average 3 hours continuous flight) in flight longevity and 
chemically induced neurotransmitters overdose could result in a recoverable 50% 
mean flight speed reduction. This combined modality could allow for a broader range 
of flight operations to be performed. 
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CHAPTER 6 
OPTOFLUIDIC WAVEGUIDES FOR RECONFIGURABLE PHOTONIC 
SYSTEMS
*
 
6.1 Abstract 
We report the development of two liquid waveguide based photonic elements for 
use in reconfigurable photonic systems.  This work demonstrates the ability to couple 
light from a conventional optical fiber to an adaptable liquid-core/liquid-cladding 
waveguide and back again to an optical fiber(s) enabling us to take advantage of both 
liquid- and solid-state photonic modalities.  We demonstrate and characterize the use 
of this fiber-in and fiber-out system as either an optical switch or signal attenuator.  
Microscale flow control enables the adaptive morphology and tunable position of the 
liquid waveguide yielding an attenuation range of 3.1-10.7 dB, operability over a 
broad bandwidth spanning the range of wavelengths from visible to 
telecommunication, and a 1x2 sub-second switching system with a cross-talk as low as 
20 dB and maximum coupling efficiency of 3.87 dB. 
 
 
 
  
 
                                                 
*
Reprinted by permission of the Optical Society of America (OSA) with permission from Aram J. 
Chung and David Erickson, “Optofluidic waveguides for reconfigurable photonic systems", Optics 
Express, 19 (9), 8602-8609 (2011), DOI: 10.1364/OE.19.008602 © OSA 
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6.2 Introduction 
A reconfigurable system is one that can dynamically adapt its properties or function 
in response to an externally issued command or autonomously in response to changes 
in operational conditions.  In electronics, the FPGA (Field Programmable Gate Array) 
[1] is the ubiquitous example of such a system in that it can provide “on-the-fly” 
reconfigurability by reprogramming the hierarchy of interconnections between 
different logic blocks.  Despite the advantages, there are very few other microsystem 
based fields which have demonstrated technologies that exhibit anywhere near the 
level of reconfiguration possible through FPGAs. 
A key factor for the development of an analogous high-performance reconfigurable 
photonic system would be the capability to dynamically control either (1) the physical 
layout or (2) the refractive indices of the optical components.  Recent advancements in 
optical MEMS technology [2-4] has provided significant functionality and flexibility 
to the former of these techniques.  With regards to the latter, traditional techniques for 
manipulating the refractive index through electro-optic [5, 6], magneto-optic [7], 
acousto-optic [8, 9], thermo-optic [10], and carrier injection [11] techniques are 
limited by the achievable ∆n/n  (see Erickson et al. [12] for details and a tabulated 
comparison).  The practical implication of a smaller ∆n/n is that either a longer 
interaction length is required (occupying more on-chip space) or resonant elements 
must be incorporated (reducing the bandwidth). 
Recent developments in optofluidics [13, 14]
 
have demonstrated how incorporating 
microfluidic elements into photonic systems can yield much higher ∆n/n.  For 
example, Erickson et al. [15], reported high refractive index modulation of the 
photonic crystal circuits using nanofluidics.  The disadvantage of these approaches is 
that while broad tunability can be obtained, the base optical elements (e.g. photonic 
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crystals [15, 16] and ring resonators [17, 18]) must be incorporated at the fabrication 
stage.  Although a number of pure fluid state photonic elements, like waveguides [19, 
20], microlenses [21, 22], and dye lasers [23, 24] have been demonstrated, they are not 
often used to directly physically reconfigure elements within a solid-state photonic 
system.  The advantage of using fluidics in comparison with the MEMS based 
reconfigurability approaches listed above is that the physical displacement of the 
optical elements can be much larger.  
In this paper, we demonstrate the use of high performance liquid-core/liquid-
cladding waveguides to achieve optical attenuation and 1x2 switching in a fiber-in and 
fiber-out system.  Previously we reported a numerical study [25] on a hybrid system 
for coupling light between liquid- and solid-state waveguides, demonstrating the 
potential to achieve high coupling efficiencies using a fluid enveloping “end-fire” type 
technique.  Here we implement this technique experimentally demonstrate coupling 
efficiencies as high as 48.98% (including all losses from the input fiber to the output 
detector).  Recently, Seow et al. [26] and Lim et al. [27] also reported liquid-core 
based switching systems, with the latter demonstrating a high-speed 2x3 fiber-in and 
fiber-out switch.  Here we demonstrate analogous switching but also introduce: the 
ability to perform controlled the attenuation, a single layer fabrication technique 
optimized for achieving low cross-talk (less than 20 dB), and characterize the system 
over the broader bandwidth including visible and telecommunication wavelengths.  By 
integrating liquid- and solid-state photonic modalities on a single chip, we hope this 
hybrid system can become an element of a new type of photonic element for use in 
reconfigurable photonic and optical communication systems. 
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Figure 6.1.  Schematic views of (a) the optofluidic system showing the principle of 
operation for the optical switch (upper image) and the tunable modulator (lower 
image) (b) Experimental setup showing the coupling of the optical and flow control 
systems to the chip.  
6.3 Principles of operation, device design and experimental setup 
We demonstrate here two hybrid fiber-in and fiber-out reconfigurable optofluidic 
systems: (1) a 1x2 optical switch and (2) a tunable attenuator.  The operating principle 
of both these devices is shown schematically in Fig. 6.1(a).  Briefly, in both cases light 
is first coupled from the input optical fiber to the adaptable liquid-core/liquid-cladding 
waveguide.  In the case of the switch the liquid waveguide is then directed to one of 
the two output fibers by changing the input pressure of one of the cladding flows.  For 
the attenuator we modulate the power transferred from the input to the output optical 
fiber by adjusting the width of the liquid-core waveguide.  This is done by increasing 
or decreasing the pressure of both cladding flows equally. 
To form the liquid-core/liquid-cladding waveguide [19], a solution of 5.0 M 
Calcium Chloride (CaCl2, n~1.44) is introduced as the core solution and two low 
refractive index streams of DI water (n~1.33) are used as the cladding.  For the 
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waveguide visualization experiments shown below, the core fluid was also doped with 
FITC (fluorescein isothiocyanate) dye.  For all excitation wavelengths multi-mode 
fiber (MMF, outer diameter = 125 µm, core diameter = 105 µm, and nominal 
numerical aperture NA = 0.22) was used for both the input and output channels.  We 
used MMF here since they are often preferred to single mode fibers in optical 
communication due to their lower cost and relative ease of in-coupling.  Unless 
otherwise noted below, all experiments were conducted with a 488 nm laser with the 
output power fixed at 4.3 mW.  As illustrated in Fig. 6.1(b) the fiber is directly 
inserted into a poly(dimethylsiloxane)(PDMS) chip whose channel height was 
matched with that of the optical fiber outer diameter.  The PDMS-microchannel was 
fabricated using a conventional soft photolithography method [28].  Flows are pumped 
into the PDMS microfluidic chip using off-chip solenoid-valves and all fluid flow 
manipulation which was controlled via a customized LabVIEW program as can be 
seen in Fig 6.1(b). 
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Figure 6.2.  Optofluidic tunable attenuator (a) PDMS chip showing liquid-core/liquid-
cladding waveguide and light propagation along it.  (b) Magnified view from above 
looking at the region near liquid waveguide. (c) Minimum and maximum transmitted 
power states for the liquid waveguide. (d) Output power measurements for the 1.25 
mm liquid waveguide length: output (see supplemental Movie S1).  In all cases, scale 
bar represents 125 µm.  
6.4 Results and discussions 
6.4.1 Optofluidic attenuator 
For the optofluidic attenuator, the input and output optical fibers are directly 
coupled by the liquid waveguide.  By changing the width of the liquid core (by 
modulating the relative flow rates of the core and cladding fluids) the amount of 
power transmitted to the output fiber can be dynamically modulated.  The mode 
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profile in the liquid waveguide can be also reconfigured simply by adjusting the local 
flow conditions.  Single mode operation is possible, as demonstrated by Wolfe et al. 
[19].  As mentioned above however, here we focus primarily on multimode operation.  
The optofluidically tunable attenuator and a magnified view of the microfluidic 
arrangement at the region near liquid waveguide are showed in Fig. 6.2 (a) and (b) 
respectively.  Figure 6.2(c) and (d) illustrate the transmitted power changes as the core 
is adjusted from its maximum to minimum width (see supplemental Movie S6.1 for 
more details).  Based on the power output for the 1.25 mm waveguide length shown 
here, the observed attenuation power range was between 3.1 to 10.7 dB. 
 
Figure 6.3.  (a) Output power as a function of the waveguide width for different 
channel lengths (equivalent to liquid waveguide length). (b) Maximum power as a 
function of the liquid waveguide length ranging from 0.5 mm to 4.75 mm. The error 
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bars represents standard error of the mean. (c)  Emitted fluorescence intensity from the 
liquid waveguide as a function of downstream distance.  
In order to further characterize the optofluidic attenuator, a series of experiments 
were performed to measure the transmitted power as a function of the width and 
length of the liquid core waveguide.  Figure 6.3(a) shows results for four different 
channel lengths: 1.25, 2.25, 3.25 and 4.25 mm.  The method of least squares was used 
to fit the data points.  Figure 6.3(b) shows the maximum transmitted power trend for 
all the waveguide lengths tested here.  As can be seen in Fig. 6.3(a), regardless of the 
length of the liquid waveguide a linear response of the output power was observed as a 
function of the core width.  It was however also observed that when the core size 
became much larger than that of the optical fiber, the transmitted power was also 
reduced.  As expected, the maximum transmitted power tended to decrease for longer 
liquid waveguides.  The inconsistency in the slope and variability in the maximum 
coupled power with waveguide length, seen in Figs. 6.3(a) and (b), was a repeatable 
effect and likely the result of irregular reflections off the waveguide surface and mode 
mismatching between the liquid waveguide and the output optical fiber.  
Commercially available tunable attenuators have a higher variable attenuation range 
but tend to have much higher power insertion loss.  In addition, the material costs for 
manufacturing fluid based attenuators such as this one could be much lower, given 
that only 6 g of PDMS are required at an approximate cost of 50 cents. 
To characterize the loss in the liquid waveguide itself we performed an experiment 
where the liquid waveguide was doped with a florescent dye and the change in emitted 
intensity was measured as a function of the downstream distance.  Figure 6.3(c) shows 
the intensity profile for a 120 µm wide waveguide for two centimeters of propagation 
distance.  With these results, we calculate the waveguide loss is 0.451 dB/mm.  Note 
that the waveguide loss calculated here includes the loss due to the florescent dye 
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absorption.  We expect that major cause for this loss was diffusive broadening of the 
core and cladding interface (see Jung et al. [25] for a numerical analysis of the 
relationship between light propagation and diffusion as a function of Peclet number).  
Reduction of this loss could be achieved through the use of immiscible fluids [29]. 
 
Figure 6.4.  (a) Optofluidic switch showing carbon black added to the bottom 
substrate in order to reduce cross-talk between the two output optical fibers.  (b) 
Optical micrograph view of the red dashed zone in (a).  (c) Photographic image of the 
1x2 optofluidic switch in both states.  (d) Magnified view of the switching states.  In 
all cases, scale bar represents 125 µm.  
6.4.2 Optofluidic switch 
As briefly mentioned above, the optofluidic switching element operates through 
pressure manipulation of the core and cladding fluids, directing the position of the 
liquid waveguide so that it out couples to one of the output optical fibers.  Figure 
6.4(a) shows the optofluidic chip and Fig. 6.4(b) shows a magnified view of the 
microfluidic channel layout.  To reduce cross-talk between the two output channels, 
carbon black was introduced during the PDMS polymerization process (2.4 % wt/wt 
with a 5:1 mass ratio of the base to the curing agent for the PDMA).  Optofluidic 
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switching between the two states of a 1x2 switch is shown in Figs. 6.4(c) and (d) (see 
supplemental Movie S6.2 for more details).  In both these figures the liquid waveguide 
was doped with fluorescent dye to facilitate visualization.   Note that the presence of 
the carbon black significantly interferes with fluorescent imaging, resulting relative 
poor quality of the images.  In this paper, we demonstrate a 1x2 switching system 
however we note that it could be expanded to a 1xN system for higher performance 
applications. 
 
Figure 6.5.  Output power vs. switching period for (a) 5 seconds, (b) 3 seconds, (c) 1 
second, and (d) 0.5 seconds. (Inset) Maximum power plot for each switching period.  
The error bars represents standard error of mean.  
Figure 6.5 shows the relationship between the measured output power and the 
switching period.  The two output channels are represented by blue and red lines.  As 
expected, when the switching period is decreased from 5 seconds to 0.5 seconds, the 
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maximum output power is also decreased from 0.584 mW to 0.0907 mW.  The 
maximum coupled power for all switching periods is plotted in the inset of Fig. 6.5(d).  
For these experiments, cross-talk is defined as the ratio of the power coupled into the 
on fiber to that coupled into the off fiber.  Without carbon black doping of the PDMS, 
the cross-talk was on the order of 10 dB.  Introducing carbon black into the chip 
served to absorb the vast majority of the truant scattered light in the system, reducing 
the cross-talk down to the 20 dB levels shown in Fig. 6.5. As can be seen, the quality 
of the switching also decreased for quicker switching periods placing an upper limit on 
the rate at which this technique could be used to reconfigure a photonic system.  
Higher performance may be able to be obtained either by introducing immiscible 
fluids or using pneumatically actuated PDMS membrane microvalves as has been 
demonstrated previously [27].  Commercially available MEMS 
(Microelectromechanical systems) or prism based optical switching devices have 
shown lower cross-talk (50-80 dB) and faster switching (milliseconds) however the 
optofluidic switch has advantages including: low insertion coupling loss (3.1 dB) and 
potential cost advantages as mentioned above. 
 
Figure 6.6.  (a) Coupled power into the output waveguide as a function of core width 
for 4 different laser wavelengths.  (b) Maximum coupling efficiency for all 
wavelengths tested here.  The error bars represents standard error of the mean.  
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6.4.3 Bandwidth 
To characterize the optical bandwidth of the system the attenuated power vs. core 
width experiments described above were repeated for four different lasers with 
wavelengths of 405 nm, 488 nm, 1064 nm, and 1550 nm.  All experiments were done 
using a 1.25 mm liquid waveguide as it showed the maximum transmitted power in the 
earlier experiments (see Fig. 6.3(b)).  Since each test laser had a different input power 
value, the output power of the chip was normalized against the input power to the chip 
from the waveguide.   As illustrated in Fig. 6.6(a), the output power for all 
wavelengths showed a linear response to waveguide width for both visible and 
telecommunication wavelengths.  Figure 6.6(b) shows the maximum output power as a 
function of wavelength.  These results show a peak at the blue end of the visible 
spectrum and match well with the water absorption spectrum suggesting that this is the 
limiting factor in the bandwidth of our system.  Higher performance can be obtained 
by using waveguiding fluids whose absorption spectrum are better matched to the 
wavelength range of interest.  For example, at 1550 nm, heavy water would be 
preferable as a waveguiding fluid for lower optical absorption [30]. 
6.5 Conclusion 
We present here a new approach to reconfigurable photonics which couples the 
physical adaptability of microfluidic waveguides to fiber-in and fiber-out optical 
systems.  Our efforts focused on the development of two components that could form 
the basis of a more complex reconfigurable photonic system: a signal attenuator and a 
1x2 optical switch.  By integrating liquid- and solid-state photonic modalities onto a 
single chip, we have demonstrated high coupling efficiency (3.1 dB), low cross-talk 
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(less than 20 dB), and demonstrated good performance over a broad range of 
wavelengths from visible and telecommunication.  
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CHAPTER 7 
CONCLUSIONS 
I was able to develop (1) rapid, low power drug delivery devices for insect 
biorobots and (2) optofluidic reconfigurable photonic systems.  Below, I present the 
summary of my research accomplishments and contributions by project: 
7.1. Summary of Individual Accomplishments by Project 
7.1.1. Electrokinetic microfluidic devices for rapid, low power drug delivery in au-
tonomous microsystems  
 
• Implantable, low power and rate controllable drug delivery systems designed for 
autonomous microsystems as little as 20 mJ of energy consumption. 
• Using a combination of electroosmotic and electrophoretic effects controlled 
through an electric potential, rapid drug delivery with an improvement on the 
order of approximately 130-fold compared to the diffusion based system [1].  
• Detailed three dimensional numerical simulations to model the electrokinetic 
transport involved in the electrokinetic ejection process. 
• Providing a physical insight in to the transport mechanism, the simulations re-
vealed that the majority of the contents are ejected early in the process.  
7.1.2. Engineering insect flight metabolics using immature stage implanted micro-
fluidics  
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• A method of exerting chemical control over insect flight activity, exploiting the 
use of immature stage implanted microfluidics to reversibly control the rate of 
metabolic output. 
• First step towards the development of an artificial insect nervous system where 
the controlled release of inhibitory or excitatory neurotransmitters could be ac-
complished in response to external stimuli. 
• Behavior controls ranging from retarded motion to complete, reversible paraly-
sis, over timescales ranging from minutes to hours. 
• A new paradigm for insect flight control alongside established electrical tech-
niques and for basic component of an eventual artificial insect nervous system. 
7.1.3. A robust, electrochemically driven microwell drug delivery system for con-
trolled vasopressin release 
• Implantable microreservoir device that enables delivery of dose volumes as 
high as 15 µl using an electrochemically based transport mechanism. 
o Significant reduction in the amount of time required for drug delivery 
as well as reducing the dependence on the external physiological condi-
tions 
o Potential usage for the medical use for hemorrhagic shock through re-
lease of vasopressin 
• Actively propel the drugs using a combination of electrolytic and gold dissolu-
tion reactions induced by the application of a voltage.  
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• An ejection rate as high as 4.19 µl/min with a maximum power consumption of 
approximately 5 mW. 
7.1.4. Hybrid techniques for modulating insect flight activity and longevity  
• An integrated microsystem that uses both chemical and electrical methods to 
modulate the flight activity of Manduca sexta moths. 
• Characterization of performance, recovery and endurance times of insects sub-
jected to hybrid chemical and electrical stimulations. 
• 35-fold improvement (on average 3 hours continuous flight) in flight longevity 
compared to mechanical stimulation. 
• 50% mean flight power output reduction achieved with the proper neurotrans-
mitter dose. 
7.1.5. Optofluidic waveguides for reconfigurable photonic systems 
• New approach to reconfigurable photonics which couples the physical adapta-
bility of microfluidic waveguides to fiber-in and fiber-out optical systems. 
• Two components that could form the basis of a more complex reconfigurable 
photonic system: a signal attenuator and a 1x2 optical switch. 
• High coupling efficiency (3.1 dB) and low cross-talk (less than 20 dB). 
• Performance over a broad range of wavelengths from visible and telecommu-
nication. 
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7.2. Major challenges  
This section states the major problems that I faced over the course of my Ph.D.  
Following challenges have been set to investigate more in detail and all solutions have 
described in Chap. 2-6.  
7.2.1. Electrokinetic microfluidic devices for rapid, low power drug delivery in au-
tonomous microsystems  
• Granting proper robustness of the suspending gold membrane (100 nm). 
• Avoiding the rupture of the pyramidal reservoir (~100 nL) during the filling up 
procedure. 
7.2.2. Engineering insect flight metabolics using immature stage implanted micro-
fluidics 
• Determination of the optimal location and timing to implant of the microdevic-
es. 
• Determination of the effective chemicals that could modulate moths’ flight ca-
pability including full paralysis, deceleration and stimulation. 
• Developing a mechanical stimulation apparatus in a closed gas measurement 
system to gauge the change in the carbon dioxide level. 
7.2.3. A robust, electrochemically driven microwell drug delivery system for con-
trolled vasopressin release 
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• Sampling a small volume of the ejected vasopressin into phosphate buffered 
saline solution to obtain the concentration profile as a function of time. 
7.2.4. Hybrid techniques for modulating insect flight activity and longevity  
• Flight power quantifications of the effectiveness of the chemicals via the angle 
measurements setup. 
• Insertion of the electrical stimulation electrode while marinating minimized 
impairment of the central nerve system. 
• Designing multi-output wireless transceivers to actuate multi-reservoir micro-
fluidic drug delivery system. 
• Eliminating the electrical cross-talk between electrical shocking mode and 
chemical ejection mode. 
• Quantification of the moths’ flying trajectory under VICON system without 
being affected by the local current in the room. 
7.2.5. Optofluidic waveguides for reconfigurable photonic systems 
• Minimizing the cross-talk between two on/off states that degrades the quality 
of switching performance.  
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7.3. Concluding Remarks 
I believe my work has shown how microfluidics can be integrated with other two 
fields: biology and optics.  Demonstration of the fusing a living system with an 
implanted microfluidics has shown a new way of the interfacing living creatures with 
MEMS based robotic control components.  With regards to the optofluidics, I have 
presented how liquid based photonic components can be integrated into conventional 
optical components to form a reconfigurable photonics.  In conclusion, the idea of 
combining microfluidics with other modalities enables to create novel tools to solve 
problems at the interface between life and physical sciences.  My hope is that other 
researchers will adopt and expand this concept further into other areas to solve 
complex multidisciplinary problems.   
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